WO2005053784A2 - Lead stabilization devices and methods - Google Patents

Lead stabilization devices and methods Download PDF

Info

Publication number
WO2005053784A2
WO2005053784A2 PCT/US2004/033156 US2004033156W WO2005053784A2 WO 2005053784 A2 WO2005053784 A2 WO 2005053784A2 US 2004033156 W US2004033156 W US 2004033156W WO 2005053784 A2 WO2005053784 A2 WO 2005053784A2
Authority
WO
WIPO (PCT)
Prior art keywords
lead
anchor
stent
tether
connector
Prior art date
Application number
PCT/US2004/033156
Other languages
French (fr)
Other versions
WO2005053784A3 (en
Inventor
Robert E. Atkinson
Peter T. Keith
Michael Berman
Original Assignee
Aetherworks I, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aetherworks I, Inc. filed Critical Aetherworks I, Inc.
Priority to EP04794493A priority Critical patent/EP1722847A4/en
Priority to US11/139,894 priority patent/US7797053B2/en
Publication of WO2005053784A2 publication Critical patent/WO2005053784A2/en
Publication of WO2005053784A3 publication Critical patent/WO2005053784A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • A61N1/057Anchoring means; Means for fixing the head inside the heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0076Quadric-shaped ellipsoidal or ovoid

Definitions

  • the present invention generally relates to medical devices and methods. More specifically, the present invention relates to medical devices and methods for stabilizing leads in cardiac vasculature. Background of the Invention [002] Heart failure is an increasingly common condition worldwide.
  • CRT Cardiac resynchronization therapy
  • the lead that stimulates the left ventricle is positioned via the coronary sinus into a cardiac vein along the free wall of the left ventricle.
  • Post procedural challenges related to the left ventricular lead include lead dislodgement prior to fibrosis, loss of stimulation capture, and lead removal necessitated by infection.
  • Currently available left ventricular leads have generally been designed to facilitate effective delivery and provide fatigue resistance, and are particularly susceptible to dislodgement both intra-procedurally and post- procedurally. Efforts to incorporate more aggressive anchoring into the lead body have generally been insufficient for preventing dislodgment, and/or have compromised effective delivery, fatigue resistance and subsequent lead removal. Summary of the Invention [005] Therefore, a need exists to enable effective lead stabilization without compromising lead delivery, resistance to lead fatigue, or lead removal.
  • the lead stabilization mechanisms described herein may be separate from but cooperative with the lead, thus allowing independent delivery and function.
  • the lead may be designed for effective delivery and fatigue resistance
  • the stabilization mechanism may be designed for effective acute and/or chronic anchoring to prevent lead dislodgement.
  • the stabilization mechanisms described herein may be separable from the lead to permit subsequent lead removal.
  • Figure 1 is an anterior view of a human heart and associated vasculature
  • Figure 2 is a posterior view of a human heart and associated cardiac venous vasculature
  • Figure 3 is a schematic side view of a lead and an anchor device in the form of a stent disposed in a cardiac vein
  • Figure 4 is a schematic side view of a lead and an alternative anchor device in the form of a stent disposed in a cardiac vein
  • Figure 5 is a schematic side view of a lead disposed in a coronary vein and an alternative anchor device in the form of a stent disposed in a secondary cardiac vein
  • Figure 6 is a schematic side view of an anchor delivery device for use in delivering the anchor devices illustrated in Figures 3 - 5
  • Figure 7 is a schematic side view of a lead and an alternative anchor device in the form of a coil disposed in a cardiac vein
  • Figure 8 is
  • FIG. 1 shows the anatomy of a human heart (H) is illustrated.
  • Figure 1 shows the heart from the anterior side, with the right chambers of the heart shown in section.
  • Figure 2 shows the heart from the posterior side, and illustrates the cardiac veins, including the coronary sinus (CS) and its associated venous branches (great cardiac vein, left marginal vein, left posterior ventricular vein, middle cardiac vein, and small cardiac vein).
  • CS coronary sinus
  • the CS carries the primary venous return for the cardiac circulation, with the venous branches distributed about the heart and draining into the CS.
  • the CS circumnavigates the left side of the heart, generally between the left atrium (LA) and the left ventricle (LN).
  • the CS drains into the right atrium (RA) at the ostium.
  • Left ventricular leads are typically implanted with the proximal end connected to a pulse generator in a subcutaneous or submuscular pocket, and the distal end (electrode(s)) disposed in one of the cardiac veins to stimulate the left ventricle.
  • the lead body typically extends from the pulse generator in the subcutaneous or submuscular pocket, through the vein wall and into the left subclavian vein (LSN), through the left brachio-cephalic vein (LBN), down the superior vena cava (SNC) and into the right atrium (RA), into the CS and into the target cardiac vein.
  • the venous circulation is usually accessed by introducing delivery catheters (called guide catheters or guide sheaths) from a venous arteriotomy in the LSN to the CS ostium, following the dashed line shown in Figure 1.
  • guide catheters called guide catheters or guide sheaths
  • a coronary venogram is obtained to visualize the cardiac veins.
  • the lead is advanced into the CS and the desired cardiac vein, following an exemplary path indicated by the dashed line shown in Figure 2.
  • LN leads over-the-wire (OTW) leads
  • stylet-delivered leads incorporate a guide wire lumen which extends through the entire lead body, emerging at the tip of the lead. Navigation within the CS and cardiac veins is performed by advancing a steerable guide wire to a desired location in a cardiac vein, and the lead is then advanced over the guide wire.
  • Stylet delivered leads have a stylet lumen which extends through the lead body, but typically terminates proximal of the distal tip.
  • a shaped styled is positioned in the stylet lumen and the lead and stylet are advanced together to navigate the lead to a desired location in a cardiac vein.
  • the delivery catheter is removed. Depending on the particular lead, and the type of electrical connector utilized, removal is accomplished either by withdrawing the delivery catheter over the proximal end of the lead, or by splitting the delivery catheter as it is removed over the proximal end of the lead. In some situations, removal of the delivery catheter may dislodge the lead, as the stability of the lead position is often quite tenuous.
  • a pacing lead 10 and an anchor device in the form of a stent 20 are schematically shown disposed in a cardiac vein CN.
  • the CN generically refers to venous braches of the coronary sinus such as the great cardiac vein, left posterior ventricular vein, middle cardiac vein, small cardiac vein, or other cardiac vein that leads to the left ventricle, and preferably that leads to the apex of the left ventricular free wall or that otherwise provides for effective pacing of the left ventricle.
  • Lead 10 may comprises a conventional pacing lead having an elongate body or shaft 12 and one or more electrodes 14 connected to a pulse generator (not shown) by corresponding wires or traces inside the lead body 12.
  • Lead 10 is generally designed to be very flexible and fatigue resistant to permit free cardiac movement, to minimize tissue trauma, and to withstand repeated flexure primarily caused by the beating heart.
  • the electrodes 14 are typically positioned on or near the wall of the vein facing the heart to establish effective conduction into the heart wall.
  • Stent 20 may be self-expandable or balloon expandable, for example, and may be formed of a biocompatible metal material such as stainless steel, Nitinol, Elgiloy, or MP35N.
  • stent 20 may be formed of a biodegradable polymeric material such as poly-L-lactic acid, polyglycolic acid, or polycaprolactone, or other biodegradable materials such as those used for biodegradable sutures.
  • the polymer may be loaded with a radiopaque agent such as barium, bismuth subcarbonate, etc. to facilitate x-ray visualization.
  • Stent 20 may be connected to lead 10 by an elongate connector 30.
  • Elongate connector 30 may comprise a tether that is flexible and fatigue resistant, including monofilament and multifilament polymeric constructions.
  • the tether 30 may comprise a braided cord of a high strength biocompatible polymer such as polyester, polypropylene, or polyethylene (e.g., Spectra brand).
  • the tether 30 may be partially or fully covered or coated with a material that promotes tissue in-growth such as ePTFE.
  • the tissue in-growth promoting material may serve to secure the elongate member 30 to the lead 10 and/or prevent bacteria migration along the elongate member 30.
  • the elongate member or tether 30 extends through the lumen (e.g., guide wire lumen) of the lead 10.
  • This embodiment is particularly suitable for OTW leads that typically have a guide wire lumen extending therethrough.
  • the tether 30 may have an outside diameter that is less than the inside diameter of the guide wire lumen of the lead 10, such as 0.004 to 0.016 inches, for example.
  • the proximal end of the tether 30 may extend out the proximal end of the lumen of the lead 10, and may be connected to the lead 10 by tying a knot that is larger than the diameter of the lumen, for example.
  • the proximal end of the tether 30 may be connected to the proximal end of the lead 10 by trapping the tether 30 in the lumen of the lead 10 with a wedge or pinching it between the electrical connector of the lead 10 and the socket of the pulse generator.
  • the distal end of the tether 30 may be connected to the stent 20 by tying the tether 30 in a knot around a strut of the stent 20, or swaging and end of the tether 30 between struts of the stent 20, for example.
  • the stent 20 and tether 30 may be deployed before the lead 10 is delivered.
  • the stent 20 may be deployed in a distal portion of the target CN with a delivery device as described in more detail with reference to Figure 6.
  • the proximal end of the tether 30 may be inserted into the distal end of the lumen extending through the lead 10, and the lead 10 may then be advanced over the tether 30 and into the CN to the desired position, and pacing tests may be performed to ascertain LN pacing capture. Once the lead 10 is in the desired position, the proximal end of the tether 30 may be secured to the proximal end of the lead 10 as described previously.
  • the lead 10 may be removed from the CN by disconnecting the tether 30 from the lead 10 (e.g., by cutting the knot in the tether 30 at the proximal end of the lead 10), the tether 30 may be removed from the CN by disconnecting the tether 30 from the stent 20 (e.g., by using a cutting device as described in more detail with reference to Figure 12), and the stent 20 may be left in place in the CN without compromising blood flow through the CN.
  • an alternative anchor device arrangement is shown schematically. In this embodiment, rather than extending through the lumen of the lead 10, the tether 30 extends along side the lead 10.
  • This embodiment is particularly suitable for stylet-delivered leads that typically do not have a lumen extending therethrough, but may be used with either stylet-delivered or OTW leads. This embodiment also allows for the delivery of the anchor device either before or after lead 10 placement.
  • the tether 30 may be connected to the lead 10 by a fastener such as collar 40.
  • Collar 40 may comprise a short dual lumen tube including a relatively large lumen to accommodate the lead 10 therethrough and a relatively small lumen to accommodate the tether 30 therethrough.
  • Collar 40 may be fixedly connected to the lead 10 if the anchor device is delivered prior to the lead 10 by swaging, adhesive, etc.
  • the collar 40 may be slidable over the lead 10 and lock in place adjacent the distal potion of the lead 10 using a mating geometry such as a detent on the outer surface of the lead 10 that receives a protrusion extending from the inside surface of the collar 40.
  • the outer surface of the lead 10 may include a protrusion such as a stepped ridge 45 that abuts the distal end of the collar 40 as the collar 40 is advanced over the lead 10 in order to prevent proximal movement of the lead 10 relative to the collar 40.
  • the stepped ridge 45 may be an integral extension of the outer surface of the lead 10 or a separate component fixedly connected to the lead 10.
  • the tether 30 may be effectively connected to the collar 40 to prevent proximal movement of the collar 40 relative to the tether 30 by utilizing a knot or stop 35 that is slid down the length of the tether 30.
  • a knot may be made in the tether at its proximal end and advanced distally to the collar 40 using a conventional knot pusher.
  • a stop 35 may be used and configured to readily advance distally over the tether 30 and resist retraction proximally.
  • stop 35 may comprise a short tubular segment having proximal facing flanges extending from the inside surface that selectively engage the tether 30 only when the stop 35 is advanced in the proximal direction relative to the tether 30.
  • a dual lumen advancement sheath 50 may be slid (pushed) over the lead 10 and tether 30.
  • Sheath 50 may comprise an elongate dual lumen tube having a length sufficient to extend over the lead 10, through the venous vasculature, and out the venous access site, with one lumen to accommodate the lead 10 and another lumen to accommodate the tether 30.
  • Sheath 50 may include a slit (not shown) along the length thereof to facilitate peeling over the lead 10.
  • Sheath 50 may be removed over the lead 10 and tether 30 after advancement of the collar 40 and stop 35, or it may be left implanted to contain the tether 30 relative to the lead 10.
  • an alternative anchor device arrangement is shown schematically.
  • the stent 20 is deployed in a secondary cardiac vein (SCN) and connected via tether 30 and collar 40 to lead 10 as described with reference to Figure 4.
  • SCN secondary cardiac vein
  • Positioning the stent 20 in a SCV enhances the anchoring effect and, because of collateral venous circulation, reduces the possibility of adverse effects if the stent 20 were to become occluded.
  • FIG. 6 a schematic side view of an anchor delivery catheter device 100 for use in delivering anchor devices such as stent 20 as described in connection with the embodiments of Figures 3 - 5.
  • the delivery device 100 is configured to deliver an elastically expandable (self-expanding) stent, but a balloon catheter type delivery device may alternatively be utilized to deliver a plastically deformable (balloon expandable) stent.
  • the delivery catheter 100 may include an inner tube 110 coaxially disposed in an outer tube 120.
  • the stent 20 may be pre-loaded inside the outer tube 120, near its distal end.
  • the distal end of the inner tube 110 abuts the proximal end of the stent 20, and may be advanced distally with respect to the outer tube 120 as indicated by arrow 115 to advance stent 20 out of the distal end of the outer tube 120.
  • the tether 30 may be disposed between the inner tube 110 and the outer tube 120.
  • One or more sensing or test electrodes (not shown) may be disposed on a distal portion of the outer tube 120, with corresponding wires extending proximally therefrom for connection to an ECG monitor or an external pulse generator.
  • the sensing or test electrode(s) may be used to measure ECG signals and/or deliver pacing signals in order to electrically map the CS and/or CN, and/or to determine a desirable position for the lead electrodes 14, preferably prior to deployment of the stent anchor 20.
  • the use of such sensing or test electrodes may be incorporated into other delivery anchor device systems described elsewhere herein.
  • a guide wire 130 may be used to initially navigate the CN. Once the guide wire 130 is in the desired position, the delivery catheter 100 with the pre-loaded stent 20 therein may then be advanced over the proximal end of the guide wire 130 and advanced thereover to the desired deployment position.
  • the inner tube 110 may be advanced in the distal direction with respect to the outer tube 120 as indicated by arrow 115 to deploy the stent 20 in the CV. Once the stent 20 is deployed, the delivery catheter 100 may be removed.
  • an alternative anchor device arrangement is shown schematically.
  • a coil 70 is deployed distal of the lead 10 and connected via tether 30 to lead 10 as described with reference to Figure 3.
  • the proximal end of the coil 70 may be connected to the distal end of the tether 30 at connection 75, and the coil 70 may comprise a resilient structure such as a metal wire formed of any of the materials described with reference to stent 20.
  • Coil 70 may be delivered via a lumen (e.g. guide wire lumen) extending through the lead 10 and is particularly suitable for an
  • the coil 70 may be advanced through the lumen of the lead 10 using a push tube (not shown) having sufficient column strength disposed over the tether 30 that abuts the connection 75 between the coil 70 and the tether 30. [048] To accommodate delivery through the lumen extending through the lead 10, the coil 70 may have a delivery configuration wherein the coil 70 is elongated to have a reduced profile sufficiently small to fit into the lumen, and a deployed configuration wherein the coil 70 is radially expanded to have an expanded profile sufficiently large to frictionally engage the wall of the CN.
  • the coil 70 may be highly elastic such that it assumes the deployed configuration automatically upon advancement out of the distal end of the lead 10, or the coil may be actuated (e.g., thermally) upon advancement out of the distal end of the lead 10 to assume the deployed configuration.
  • an alternative anchor device arrangement is shown schematically.
  • a bundle 80 is deployed distal of the lead 10 and connected via tether 30 to lead 10 as described with reference to Figure 3.
  • the proximal end of the bundle 80 may be connected to the distal end of the tether 30 at connection 85, and the bundle 80 may comprise a resilient structure such as a metal wire formed of any of the materials described with reference to stent 20.
  • Bundle 80 may be delivered in the same manner as and may have the same or similar characteristics as coil 70 described with reference to Figure 7.
  • Bundle 80, as opposed to coil 70, may have an occlusive effect, and therefore may be particularly suitable for a SCN to take advantage of collateral venous circulation.
  • an alternative anchor device arrangement is shown schematically. This embodiment is similar to the embodiment illustrated in Figure 5, except that a plug 90 is used in place of stent 20.
  • the plug 90 may comprise a curable adhesive (e.g., cyanoacrylate, EN A in a DSMO solvent) or an embolic coil, for example, such as those conventionally used in occluding blood vessels and aneurisms.
  • a curable adhesive e.g., cyanoacrylate, EN A in a DSMO solvent
  • an embolic coil for example, such as those conventionally used in occluding blood vessels and aneurisms.
  • Plug 90 may be deployed in a SCN using a conventional embolic delivery system and connected via tether 30 and collar 40 to lead 10 as described with reference to Figure 4. Positioning the plug 90 in a SCN enhances the anchoring effect, and despite the occlusive effect of the plug 90, the possibility of adverse effects are reduced if not eliminated due to collateral venous circulation.
  • alternative anchor device arrangements are shown schematically. In these embodiments, a wedge 140 or 150 is deployed adjacent the distal portion of the lead 10, such as proximal of electrodes 14. Wedges 140 and 150 frictionally engage the lead body 12 and the wall of the CN, to lodge the lead 10 in the desired position in the CN.
  • the wedges 140 and 150 may be connected to tether 30 to facilitate subsequent removal.
  • Wedges 140 and 150 may comprise any of the materials discussed with reference to stent 20.
  • Wedges 140 and 150 are particularly suitable for deployment after the lead 10 has been delivered to the desired position, as shown in Figures 10 and 11.
  • the wedges 140 and 150 may be deployed before the lead 10 has been delivered, with the wedges positioned distally of the desired position for the lead 10.
  • the wedge may be over-sized with respect to the inside diameter of the CN where it is to be positioned in order to cause atraumatic expansion of the CN wall around the wedge, thus enhancing friction therebetween.
  • wedge 140 includes a body portion 142 and optional threads 144.
  • Body portion 142 may include a perfusion lumen extending therethrough to permit blood perfusion from the distal end to the proximal end of the wedge 140.
  • the wedge body 142 (or the wedge threads 144 if used) may have a diameter slightly greater than the diameter of the lumen of the CN less the diameter of the lead 10 in order to provide a snug frictional fit therebetween.
  • Wedge 140 may be delivered into the desired position utilizing a push tube 60 advanced over a guide wire (not shown), for example, wherein the push tube 60 has sufficient column strength to push the wedge 140 alongside the lead 10 with the distal end 65 of the push tube abutting the proximal end of the wedge 140 and the tether 30 extending through the push tube.
  • the push tube may also have sufficient torsional strength with a distal end 65 that mates with the proximal inside diameter of the wedge 140 such that the wedge 140 may be rotated to engage or disengage the threads 144 with the lead 10 and the wall of the CN.
  • wedge 150 comprises a short dual lumen having one lumen to accommodate the lead 10 and another (crescent shaped) lumen to permit blood perfusion from the distal end to the proximal end of the wedge 150.
  • the wedge 150 may be tapered and may have a diameter slightly greater than the diameter of the lumen of the CN less the diameter of the lead 10 in order to provide a snug frictional fit therebetween.
  • Stepped ridge 45 prevents proximal movement of the lead 10 relative to wedge 150 as described previously.
  • Wedge 150 may be delivered into the desired position utilizing a push tube 50 advanced over the lead 10, as described previously.
  • a cutting device 160 is shown schematically. Cutting device 160 may be used to cut tether 30 and/or stop 35 in order to disconnect the tether 30 from the anchor device, such as stent 20. Cutting device 160 is merely an example of a variety of cutting mechanisms that may be used to sever the connection of the tether 30 from the anchor device.
  • the tether 30 may be equipped with two internal wires connected to a distal electrolytic fuse that separates (melts) upon the application of electrical current, such as those used for detachable embolic coils.
  • cutting device 160 includes an outer tube 162 and an inner tube 164 coaxially disposed and movable therein.
  • the outer and inner tubes 162 and 164 may have a length sufficient to extend from outside the vascular access site to the anchor device, and may be configured for intravascular navigation and advancement over tether 30.
  • the distal end of the inner tube 164 may have a sharpened edge and may be formed of a material that retains a cutting edge (e.g., metal).
  • a cutting hole 168 is provided adjacent the distal end of the outer tube 162 through which the tether 30 may be threaded.
  • the distal circumference of the cutting hole 168 may be sharpened and may be formed of a material that retains a cutting edge (e.g., metal)
  • the inner tube 164 may be advanced distally as indicated by arrow 166, with the sharpened distal end of the inner tube 164 and the sharpened cutting hole 168 acting as shears to cut the tether 30 at the cutting hole 168.
  • a lead 10 is shown disposed in a CN, with an anchor device in the form of a coiled stent 200 disposed near the ostium of the CS.
  • the coiled stent 200 may be positioned near the ostium of the CS, where the vessel diameter is large enough to resist becoming occluded by the presence of the coiled stent 200 next to the lead 10.
  • the coiled stent 200 may be placed elsewhere within the CS or CN in which the lead is positioned.
  • the lead 10 is eccentrically disposed in the lumen of the CS to define a relatively large crescent shaped blood perfusion lumen.
  • Coil stent 200 may be formed of a resilient material such as ⁇ itinol, Elgiloy, MP35 ⁇ , or stainless steel. Coiled stent 200 could also be formed of degradable materials such as those described in reference to stent 20 above. Coiled stent 200 may be releasably attached to the lead 10 utilizing collar 210, and collar 210 may frictionally engage the body 12 of lead 10, thus facilitating anchoring of the lead within the coronary sinus or cardiac vein. [059] With reference to Figure 13B, the collar 210 may comprise a relatively short tube 212, and may include one or more proximally oriented grips 218.
  • Grips 218 may be in the shape of finger-like projections, or circular ribs either partially or completely extending circumferentially around the inside of tube 212. Grips 218 facilitate the advancement of the collar 210 in a distal direction for delivery over lead 10, but resist proximal movement once the collar 210 is positioned in a desired anchoring location. Grips 218 may be formed of a soft resilient material such as silicone, polyurethane, polyether- block-amide, or the like. [060] To facilitate subsequent removal of the lead 10, the coiled stent 200 may be connected to the collar 210 in a detachable manner.
  • the coiled stent 200 may be connected to the collar 210 utilizing a biodegradable adhesive connecting adjacent portions of the coil 200 to the collar 210.
  • a biodegradable adhesive may degrade after the lead 10 has chronically anchored to the wall of the CS by normal tissue encapsulation. After the adhesive has degraded, the lead 10 (along with collar 210) may be removed utilizing standard techniques, with the coiled stent 200 remaining in the CS.
  • the coiled stent 200 may be secured to the collar 210 utilizing a retractable pin 220.
  • collar 210 may include two angled flanges 214 collectively defining a recess 216 in which stent coil 200 may reside.
  • Pin 220 may span the length of the recess 216 between the flanges 214, extending over the coiled stent 200 to retain the coil stent 200 in the recess 216, thus providing a connection between the stent coil 200 and the collar 214. Subsequent release of the stent coil 200 from the lead 10 may be accomplished by removing pin 220 using tether 30 which extends from the proximal end of the lead 10 to the pin 220. The proximal end of the pin 220 is connected to the distal end of the tether 30, and the pin 220 may be removed by pulling the tether 30 proximally.
  • the lead 10 and collar 210 are free from the stent coil 200 and may be removed with standard techniques, leaving stent coil 200 in the CS.
  • Delivery and deployment of the stent coil 200 and collar 210 may be facilitated by deployment sheath 230.
  • the deployment sheath 230 may comprise a tubular catheter, having a lumen extending therethrough to accommodate the lead 10 and the stent coil 200.
  • the lumen in the deployment sheath 230 may extend from a distal opening to a mid-shaft opening as used in conventional monorail style balloon catheters.
  • Coil 200 may be initially in a compressed condition, and loaded in the inside of the deployment sheath 230. If the lead 10 has a large diameter proximal connector, an optional slit 215 may be provided in the collar 220 to facilitate loading over the large diameter connector. In this case, the collar 210 and coil 200 may be positioned on the lead body 12 before the coil 200 is loaded into the deployment sheath 230. The deployment sheath 230 may be advanced distally down the body 12 of the lead 10 until the stent coil 200 and collar 210 are in the desirable location. The deployment sheath 230 may then be withdrawn proximally, with the collar 210 and stent coil 200 remaining in position on the lead 10 due to grips 218 on collar 210.
  • FIGs 14 and 15 illustrate an anchor device in the form of an anchoring catheter 300, which may be utilized to secure the position of lead 10, particularly during the removal of the guide sheath (guide catheter) used in the delivery of the lead 10. As described above, the lead stability is particularly vulnerable during the removal of the guide sheath.
  • the anchoring catheter 300 is positioned next to the lead 10 after lead 10 has been positioned in a desired location. Anchoring catheter 300 may be advanced within the guide sheath (not shown), generally parallel to the lead body 12, or may be advanced outside the guide sheath.
  • Shaft 312 may comprise a proximal shaft portion 312A connected by adhesive, for example, to a distal shaft portion 312B.
  • a luer adaptor 316 may be connected to the proximal end of the proximal shaft portion 312A for connection to an inflation apparatus (not shown) such as a syringe.
  • An inflatable balloon 314 may be connected to the distal end of the distal shaft portion 312B, and may be formed of elastomeric material or a molded inelastic material.
  • Proximal shaft portion 312A may be relatively stiff and may be formed of a metallic tube such as a stainless steel hypotube.
  • Distal shaft portion 312B may be relatively flexible and may be formed of a polymeric tube, for example.
  • a core wire may be connected to and extend from the distal end of the proximal shaft portion 312A.
  • the core wire 320 may comprise a metal wire such as a tapered stainless steel mandrel.
  • Core wire 320 extends to the distal end of the balloon 314, and may extend beyond with an atraumatic spring tip, for example.
  • the distal end of the balloon 314 may be bonded to the core wire 320, and the proximal end of the balloon 314 may be bonded to the distal end of the distal shaft portion 312B.
  • Within the shaft 312 is a lumen through which inflation medium is infused to inflate balloon 314.
  • FIG. 16A - 16E various embodiments of retrievable anchor devices are shown in expanded state. These retrievable (i.e., repositionable and/or removable) designs are similar to the self-expanding stent anchor embodiment described with reference to Figures 3 and 6, the general aspects of which may be applied hereto.
  • the self-expanding anchor 20 is configured to be collapsed and retracted into a retrieval tube 128 (similar to outer tube 120) by pulling proximally on the tether 30 and/or by pushing distally on the retrieval tube 128.
  • a pull chord (not shown) separate from the tether 30 may be used to collapse and retract the anchor 20 into the retrieval tube 128.
  • the pull chord may be connected to a proximal end of the anchor 20 and the tether 30 may be connected to the anchor 20 distal of the proximal end thereof.
  • the retrieval tube 128 may have a distal inside taper or funnel shape to facilitate collapse of the self-expanding anchor 20 when pulled therein.
  • the retrievable anchor 20 may comprise a self-expanding braided structure 20 A. The braided structure 20A is expanded in its relaxed state and may be compressed to fit into the delivery tube 120 or retrieval tube 128.
  • the braided anchor 20 A may include a plurality (e.g., eight or more) of highly flexible and elastic elongate members formed of a metal (e.g., stainless steel, Nitinol, Elgiloy, or MP35N), for example, that cross over and under each other in a braid pattern.
  • the distal ends of the elongate members may be fused in pairs and/or shaped to face inwardly to provide an atraumatic distal edge.
  • the proximal ends of the elongate members may be connected to the tether 30 to facilitate collapse and retraction into the retrieval tube 128.
  • the snare-like 20B or basket-like 20C structures may include a plurality (e.g., two or more) of highly flexible and elastic elongate members formed of a metal (e.g., stainless steel, Nitinol, Elgiloy, or MP35N), for example, that extend generally parallel, do not cross, and bow outwardly.
  • the snare-like 20B or basket-like 20C structures are expanded in their relaxed state and may be compressed to fit into the delivery tube 120 or retrieval tube 128.
  • the retrievable anchor 20 may comprise a self-expanding stent 20D formed of a cut super elastic hypotube, for example.
  • the self-expanding stent 20D is expanded in its relaxed state and may be compressed to fit into the delivery tube 120 or retrieval tube 128.
  • the self-expanding stent 20D may be laser cut from a metallic (e.g., stainless steel, Nitinol, Elgiloy, or MP35N) hypotube, for example, having almost any desired pattern.
  • the self-expanding stent 20D has two sets of four diamonds interconnected by four middle struts.
  • the proximal set of four diamonds provide a four point crown, to which a parachute-like tether 30 may be connected to facilitate collapse and retraction into the retrieval tube 128.
  • the retrievable anchor 20 may comprise a self-expanding stent 20E having a proximal taper.
  • This stent 20E is similar to the stent 20D described above with the exception of the proximal taper.
  • the proximal taper on the stent 20E shown in Figure 16E serves a similar function as the parachute-like tether 30 shown in. Figure 16D, but provides for a single attachment point for the tether 30.
  • the tether 30 is connected to the proximal end of the tapered portion of the stent to facilitate collapse and retraction into the retrieval tube 128.
  • the attachment point (i.e., tip) of the proximal taper may be concentric with the remainder of the structure as shown, or may be eccentric.
  • FIG. 17A illustrates in more detail an example of a self- expanding stent 20E having a proximal taper.
  • the stent 20E may be formed from Nitinol tubing commercially available from Nitinol Devices & Components, Inc. (NDC) with an inside diameter of approximately 0.024 inches and an outside diameter of 0.032 inches (NDC stock SE508).
  • NDC Nitinol Devices & Components, Inc.
  • the tubing the outer surface of which is shown in an unrolled state only for purposes of illustrating the pattern, may be cut into the desired pattern using laser cutting techniques employed by Laserage, Inc., for example.
  • steps of 0.030 inches forming mandrels and briefly (e.g., 60 seconds) exposed to 500 C.
  • the formed tubing may be given its final shape set for 4 minutes at 550 C, and then may be aged at 470 C. to provide a stent that has a martensite to austenite transformation which occurs over a relatively narrow temperature range (e.g. 15 centigrade degrees).
  • the stent After expanding and heat treating the cut tubing into a formed stent 20E, the stent may be grit-blasted and electro-polished to improve the mechanical integrity of the stent and smooth sharp edges.
  • An example of a formed stent 20E is schematically shown in
  • FIGs 17B and 17C which illustrate top and side views respectively, with the proximal end (for comiection to the tether) shown to the left and the distal end shown to the right.
  • the proximal portion of the stent 20E has a tapered structure to facilitate collapse of the stent 20E into a lumen of a delivery catheter (for removal or repositioning of the stent 20E) by pulling on the tether relative to the catheter.
  • the proximal end of the stent 20E may be eccentrically disposed such that the tether and thus the lead electrodes lie against and establish good electrical contact with vascular or myocardial tissue.
  • the stent 20E may be modified from the specific embodiment illustrated.
  • the stent 20E may have a length less than 1.0 inches, or less than 0.50 inches.
  • the stent anchor 20E may have an expanded diameter of preferably approximately 125% to 200% the inside diameter of the CN where the stent 20E is to be deployed.
  • Figures 18 A and 18B illustrate how a metallic anchor may be connected to a lead body and used as a pacing electrode.
  • the anchor is shown to be a self-expanding stent anchor 20E with a proximal tapered portion to facilitate removal.
  • the anchor may comprise a metallic structure to serve as an electrode and may be electrically connected to the conductors in the lead. Electrical contact between the anchor and the lead conductors may be provided internal to the lead as shown in Figure 18A or external to the lead as shown in Figure 18B.
  • the lead 10 may be modified to have internal electrical contacts 16 exposed to the guide wire lumen and electrically connected to wires extending proximally in the lead body 12.
  • the stent anchor 20E may have a proximally disposed electrical contact 24 that is electrically connected to all or a select portion of the stent structure.
  • the electrical contacts 16 are configured to electrically and mechanically engage with electrical contact 24 such that when the lead 10 is advanced distally, the internal electrical contacts 16 engage the stent contact 24 to establish electrical connection and mechanical lock.
  • the conventional outer electrodes 14 on the lead may optionally be eliminated.
  • the conventional lead electrode(s) 14 establish direct contact with the inside of the stent structure 20E to provide and electrical connection therebetween.
  • the tether 30A may be connected to a distal strut of the stent structure 20E, extend inside the stent lumen, and pass through the guide wire lumen of the lead 10.
  • FIG. 19 illustrates an alternative anchor delivery catheter device 100, similar to the delivery device described with reference to Figure 6.
  • the delivery catheter 100 includes an inner tube 110 which extends through an outer tube 120.
  • the inner tube 110 may include a guide wire lumen portion 112 and a coextending tether lumen portion 114.
  • the inner tube may comprise a dual lumen extrusion or two tubes secured side-by-side, for example.
  • the guide wire lumen portion 112 of the inner tube may be configured to contain a guide wire 130 extending therethrough.
  • the tether lumen portion 114 of the inner tube may be configured to contain the tether 30 extending therethrough.
  • Stent anchor 20E is shown in a compressed condition inside the delivery catheter 100. Outer tube 120 maintains the stent anchor 20E in its compressed condition while the delivery catheter 100 is advanced to the desired site within the cardiac vasculature for deployment.
  • the guide wire lumen portion 112 may extend inside the compressed anchor 20E, and the tether lumen portion 114 may extend up to the proximal end of the stent anchor 20E adjacent the attachment point of the tether 30.
  • a transition member 116 may be provided at or near the distal end of the guide wire lumen portion 112, which serves to diametrically transition the guide wire lumen portion 112 with the outer tube 120.
  • a leader 36 may be connected to the tether 30 by a connection mechanism.
  • a connection mechanism includes a tubular female receptacle 34, which mates with a male insert 32.
  • Male insert 32 preferably includes curved regions that serve to increase the frictional engagement after the male insert 32 is position within the female receptacle 34.
  • connection 32/34 will be positioned proximal to the proximal end of the lead, and the connection 32/34 can thereafter be disconnected if desired.

Abstract

Devices and methods for stabilizing lead (10) in a cardiac vein.

Description

LEAD STABILIZATION DEVICES AND METHODS Field of the Invention [001] The present invention generally relates to medical devices and methods. More specifically, the present invention relates to medical devices and methods for stabilizing leads in cardiac vasculature. Background of the Invention [002] Heart failure is an increasingly common condition worldwide.
Cardiac resynchronization therapy (CRT) has shown great promise as a treatment for a large percentage of patients in various stages of heart failure. CRT involves cardiac pacing of both the left and right ventricles of the heart
(biventricular pacing), which causes both ventricles to beat simultaneously, greatly improving the pumping efficiency of the heart. Typically, the lead that stimulates the left ventricle is positioned via the coronary sinus into a cardiac vein along the free wall of the left ventricle. [003] There are numerous challenges in successfully positioning the left ventricular lead, including accessing the coronary sinus and veins, advancing the leads to a position which yields proper stimulation, and preventing subsequent lead dislodgement during removal of delivery devices.
Post procedural challenges related to the left ventricular lead include lead dislodgement prior to fibrosis, loss of stimulation capture, and lead removal necessitated by infection. [004] Currently available left ventricular leads have generally been designed to facilitate effective delivery and provide fatigue resistance, and are particularly susceptible to dislodgement both intra-procedurally and post- procedurally. Efforts to incorporate more aggressive anchoring into the lead body have generally been insufficient for preventing dislodgment, and/or have compromised effective delivery, fatigue resistance and subsequent lead removal. Summary of the Invention [005] Therefore, a need exists to enable effective lead stabilization without compromising lead delivery, resistance to lead fatigue, or lead removal. To address this need, various exemplary non-limiting embodiments are described herein which provide devices and methods for acute and/or chronic lead stabilization. By way of example, not limitation, the lead stabilization mechanisms described herein may be separate from but cooperative with the lead, thus allowing independent delivery and function. To this end, the lead may be designed for effective delivery and fatigue resistance, and the stabilization mechanism may be designed for effective acute and/or chronic anchoring to prevent lead dislodgement. In addition, the stabilization mechanisms described herein may be separable from the lead to permit subsequent lead removal. Brief Description of the Drawings [006] Figure 1 is an anterior view of a human heart and associated vasculature [007] Figure 2 is a posterior view of a human heart and associated cardiac venous vasculature; [008] Figure 3 is a schematic side view of a lead and an anchor device in the form of a stent disposed in a cardiac vein; [009] Figure 4 is a schematic side view of a lead and an alternative anchor device in the form of a stent disposed in a cardiac vein; [010] Figure 5 is a schematic side view of a lead disposed in a coronary vein and an alternative anchor device in the form of a stent disposed in a secondary cardiac vein; [011] Figure 6 is a schematic side view of an anchor delivery device for use in delivering the anchor devices illustrated in Figures 3 - 5; [012] Figure 7 is a schematic side view of a lead and an alternative anchor device in the form of a coil disposed in a cardiac vein; [013] Figure 8 is a schematic side view of a lead and an alternative anchor device in the form of a bundle disposed in a cardiac vein; [014] Figure 9 is a schematic side view of a lead disposed in a cardiac vein and an alternative anchor device in the form of a plug disposed in a secondary cardiac vein; [015] Figures 10 and 11 are schematic side views of a lead and alternative anchor devices in the form of wedges disposed in a cardiac vein; [016] Figure 12 is a schematic illustration of a release mechanism in the form of a connector cutter; [017] Figure 13 is a schematic side view of a lead disposed in a cardiac vein and an anchor device in the form of a coiled stent disposed near the ostium of the coronary sinus; [018] Figure 13A is a cross sectional view taken along line A - A in Figure 13; [019] Figure 13B is side sectional view of the fastener illustrated in Figure 13; [020] Figure 14 is a schematic side view of a lead disposed in a cardiac vein and an anchor device in the form an anchor catheter; [021] Figure 15 is a detailed schematic view of the anchor catheter illustrated in Figure 14; [022] Figures 16A - 16E are schematic side views of various retrievable anchor devices; [023] Figures 17A - 17C are more detailed schematic illustrations of a retrievable anchor device in the form of a self-expandable stent; [024] Figures 18 A and 18B are schematic illustrations of an anchor used as a pacing electrode; and [025] Figure 19 is a schematic side view of an alternative anchor delivery system for use in delivering self-expanding stent anchor devices. Detailed Description of the Invention [026] The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention. [027] With reference to Figures 1 and 2, the anatomy of a human heart (H) is illustrated. Figure 1 shows the heart from the anterior side, with the right chambers of the heart shown in section. Figure 2 shows the heart from the posterior side, and illustrates the cardiac veins, including the coronary sinus (CS) and its associated venous branches (great cardiac vein, left marginal vein, left posterior ventricular vein, middle cardiac vein, and small cardiac vein). The CS carries the primary venous return for the cardiac circulation, with the venous branches distributed about the heart and draining into the CS. The CS circumnavigates the left side of the heart, generally between the left atrium (LA) and the left ventricle (LN). The CS drains into the right atrium (RA) at the ostium. [028] Left ventricular leads are typically implanted with the proximal end connected to a pulse generator in a subcutaneous or submuscular pocket, and the distal end (electrode(s)) disposed in one of the cardiac veins to stimulate the left ventricle. The lead body typically extends from the pulse generator in the subcutaneous or submuscular pocket, through the vein wall and into the left subclavian vein (LSN), through the left brachio-cephalic vein (LBN), down the superior vena cava (SNC) and into the right atrium (RA), into the CS and into the target cardiac vein. The venous circulation is usually accessed by introducing delivery catheters (called guide catheters or guide sheaths) from a venous arteriotomy in the LSN to the CS ostium, following the dashed line shown in Figure 1. Once the CS is cannulated by a delivery catheter, a coronary venogram is obtained to visualize the cardiac veins. The lead is advanced into the CS and the desired cardiac vein, following an exemplary path indicated by the dashed line shown in Figure 2. [029] There are generally two categories of LN leads, over-the-wire (OTW) leads and stylet-delivered leads. OTW leads incorporate a guide wire lumen which extends through the entire lead body, emerging at the tip of the lead. Navigation within the CS and cardiac veins is performed by advancing a steerable guide wire to a desired location in a cardiac vein, and the lead is then advanced over the guide wire. Stylet delivered leads have a stylet lumen which extends through the lead body, but typically terminates proximal of the distal tip. A shaped styled is positioned in the stylet lumen and the lead and stylet are advanced together to navigate the lead to a desired location in a cardiac vein. [030] Once the lead is positioned in a location that yields acceptable stimulation (capture), the delivery catheter is removed. Depending on the particular lead, and the type of electrical connector utilized, removal is accomplished either by withdrawing the delivery catheter over the proximal end of the lead, or by splitting the delivery catheter as it is removed over the proximal end of the lead. In some situations, removal of the delivery catheter may dislodge the lead, as the stability of the lead position is often quite tenuous. Even if the lead is not dislodged during removal of the delivery catheter, the beating of the heart and other patient activities can cause lead movement or dislodgement, leading to potential loss of capture (effective pacing of the LN). [031] With reference to Figure 3, a pacing lead 10 and an anchor device in the form of a stent 20 are schematically shown disposed in a cardiac vein CN. Generally, the CN generically refers to venous braches of the coronary sinus such as the great cardiac vein, left posterior ventricular vein, middle cardiac vein, small cardiac vein, or other cardiac vein that leads to the left ventricle, and preferably that leads to the apex of the left ventricular free wall or that otherwise provides for effective pacing of the left ventricle. Those skilled in the art will recognize that because of anatomic variation, the precise name and position of the CV will vary. [032] Lead 10 may comprises a conventional pacing lead having an elongate body or shaft 12 and one or more electrodes 14 connected to a pulse generator (not shown) by corresponding wires or traces inside the lead body 12. Lead 10 is generally designed to be very flexible and fatigue resistant to permit free cardiac movement, to minimize tissue trauma, and to withstand repeated flexure primarily caused by the beating heart. The electrodes 14 are typically positioned on or near the wall of the vein facing the heart to establish effective conduction into the heart wall. [033] Stent 20 may be self-expandable or balloon expandable, for example, and may be formed of a biocompatible metal material such as stainless steel, Nitinol, Elgiloy, or MP35N. Alternatively, stent 20 may be formed of a biodegradable polymeric material such as poly-L-lactic acid, polyglycolic acid, or polycaprolactone, or other biodegradable materials such as those used for biodegradable sutures. In the case of polymeric materials used for stent 20, the polymer may be loaded with a radiopaque agent such as barium, bismuth subcarbonate, etc. to facilitate x-ray visualization. Generally speaking, all of the anchors of the anchor devices described herein may be formed of the aforementioned materials and may be radiopaque. Additionally, all or portions of the anchors 20 described herein may have surface modifications to increase friction and/or to promote tissue in-growth. [034] Stent 20 may be connected to lead 10 by an elongate connector 30. Elongate connector 30 may comprise a tether that is flexible and fatigue resistant, including monofilament and multifilament polymeric constructions. For example, the tether 30 may comprise a braided cord of a high strength biocompatible polymer such as polyester, polypropylene, or polyethylene (e.g., Spectra brand). The tether 30 may be partially or fully covered or coated with a material that promotes tissue in-growth such as ePTFE. The tissue in-growth promoting material may serve to secure the elongate member 30 to the lead 10 and/or prevent bacteria migration along the elongate member 30. [035] In the embodiment illustrated in Figure 3, the elongate member or tether 30 extends through the lumen (e.g., guide wire lumen) of the lead 10. This embodiment is particularly suitable for OTW leads that typically have a guide wire lumen extending therethrough. Accordingly, the tether 30 may have an outside diameter that is less than the inside diameter of the guide wire lumen of the lead 10, such as 0.004 to 0.016 inches, for example. [036] The proximal end of the tether 30 may extend out the proximal end of the lumen of the lead 10, and may be connected to the lead 10 by tying a knot that is larger than the diameter of the lumen, for example. Alternatively, the proximal end of the tether 30 may be connected to the proximal end of the lead 10 by trapping the tether 30 in the lumen of the lead 10 with a wedge or pinching it between the electrical connector of the lead 10 and the socket of the pulse generator. The distal end of the tether 30 may be connected to the stent 20 by tying the tether 30 in a knot around a strut of the stent 20, or swaging and end of the tether 30 between struts of the stent 20, for example. [037] In this embodiment, the stent 20 and tether 30 may be deployed before the lead 10 is delivered. The stent 20 may be deployed in a distal portion of the target CN with a delivery device as described in more detail with reference to Figure 6. Once deployed, the proximal end of the tether 30 may be inserted into the distal end of the lumen extending through the lead 10, and the lead 10 may then be advanced over the tether 30 and into the CN to the desired position, and pacing tests may be performed to ascertain LN pacing capture. Once the lead 10 is in the desired position, the proximal end of the tether 30 may be secured to the proximal end of the lead 10 as described previously. [038] If it is necessary or desired to remove or reposition the lead 10, the lead 10 may be removed from the CN by disconnecting the tether 30 from the lead 10 (e.g., by cutting the knot in the tether 30 at the proximal end of the lead 10), the tether 30 may be removed from the CN by disconnecting the tether 30 from the stent 20 (e.g., by using a cutting device as described in more detail with reference to Figure 12), and the stent 20 may be left in place in the CN without compromising blood flow through the CN. [039] With reference to Figure 4, an alternative anchor device arrangement is shown schematically. In this embodiment, rather than extending through the lumen of the lead 10, the tether 30 extends along side the lead 10. This embodiment is particularly suitable for stylet-delivered leads that typically do not have a lumen extending therethrough, but may be used with either stylet-delivered or OTW leads. This embodiment also allows for the delivery of the anchor device either before or after lead 10 placement. [040] The tether 30 may be connected to the lead 10 by a fastener such as collar 40. Collar 40 may comprise a short dual lumen tube including a relatively large lumen to accommodate the lead 10 therethrough and a relatively small lumen to accommodate the tether 30 therethrough. Collar 40 may be fixedly connected to the lead 10 if the anchor device is delivered prior to the lead 10 by swaging, adhesive, etc. To facilitate delivery of the lead after placement of the lead 10, the collar 40 may be slidable over the lead 10 and lock in place adjacent the distal potion of the lead 10 using a mating geometry such as a detent on the outer surface of the lead 10 that receives a protrusion extending from the inside surface of the collar 40. Alternatively, the outer surface of the lead 10 may include a protrusion such as a stepped ridge 45 that abuts the distal end of the collar 40 as the collar 40 is advanced over the lead 10 in order to prevent proximal movement of the lead 10 relative to the collar 40. With this alternative, the stepped ridge 45 may be an integral extension of the outer surface of the lead 10 or a separate component fixedly connected to the lead 10. [041] The tether 30 may be effectively connected to the collar 40 to prevent proximal movement of the collar 40 relative to the tether 30 by utilizing a knot or stop 35 that is slid down the length of the tether 30. A knot may be made in the tether at its proximal end and advanced distally to the collar 40 using a conventional knot pusher. A stop 35 may be used and configured to readily advance distally over the tether 30 and resist retraction proximally. For example, stop 35 may comprise a short tubular segment having proximal facing flanges extending from the inside surface that selectively engage the tether 30 only when the stop 35 is advanced in the proximal direction relative to the tether 30. To facilitate removal of the lead 10, the stop 35 may be cut or the tether 30 may be cut between the stop 35 and the collar 40 using the cutting device described with reference to Figure 12. [042] To facilitate advancement of the collar 40 over the lead 10 and to facilitate advancement of the stop 35 over the tether 35, a dual lumen advancement sheath 50 may be slid (pushed) over the lead 10 and tether 30. Sheath 50 may comprise an elongate dual lumen tube having a length sufficient to extend over the lead 10, through the venous vasculature, and out the venous access site, with one lumen to accommodate the lead 10 and another lumen to accommodate the tether 30. Sheath 50 may include a slit (not shown) along the length thereof to facilitate peeling over the lead 10. Sheath 50 may be removed over the lead 10 and tether 30 after advancement of the collar 40 and stop 35, or it may be left implanted to contain the tether 30 relative to the lead 10. [043] With reference to Figure 5, an alternative anchor device arrangement is shown schematically. In this embodiment, the stent 20 is deployed in a secondary cardiac vein (SCN) and connected via tether 30 and collar 40 to lead 10 as described with reference to Figure 4. Positioning the stent 20 in a SCV enhances the anchoring effect and, because of collateral venous circulation, reduces the possibility of adverse effects if the stent 20 were to become occluded. [044] With reference to Figure 6, a schematic side view of an anchor delivery catheter device 100 for use in delivering anchor devices such as stent 20 as described in connection with the embodiments of Figures 3 - 5. In this embodiment, the delivery device 100 is configured to deliver an elastically expandable (self-expanding) stent, but a balloon catheter type delivery device may alternatively be utilized to deliver a plastically deformable (balloon expandable) stent. In the illustrated embodiment, the delivery catheter 100 may include an inner tube 110 coaxially disposed in an outer tube 120. The stent 20 may be pre-loaded inside the outer tube 120, near its distal end. The distal end of the inner tube 110 abuts the proximal end of the stent 20, and may be advanced distally with respect to the outer tube 120 as indicated by arrow 115 to advance stent 20 out of the distal end of the outer tube 120. The tether 30 may be disposed between the inner tube 110 and the outer tube 120. [045] One or more sensing or test electrodes (not shown) may be disposed on a distal portion of the outer tube 120, with corresponding wires extending proximally therefrom for connection to an ECG monitor or an external pulse generator. The sensing or test electrode(s) may be used to measure ECG signals and/or deliver pacing signals in order to electrically map the CS and/or CN, and/or to determine a desirable position for the lead electrodes 14, preferably prior to deployment of the stent anchor 20. The use of such sensing or test electrodes may be incorporated into other delivery anchor device systems described elsewhere herein. [046] To facilitate delivery, a guide wire 130 may be used to initially navigate the CN. Once the guide wire 130 is in the desired position, the delivery catheter 100 with the pre-loaded stent 20 therein may then be advanced over the proximal end of the guide wire 130 and advanced thereover to the desired deployment position. The inner tube 110 may be advanced in the distal direction with respect to the outer tube 120 as indicated by arrow 115 to deploy the stent 20 in the CV. Once the stent 20 is deployed, the delivery catheter 100 may be removed. [047] With reference to Figure 7, an alternative anchor device arrangement is shown schematically. In this embodiment, a coil 70 is deployed distal of the lead 10 and connected via tether 30 to lead 10 as described with reference to Figure 3. The proximal end of the coil 70 may be connected to the distal end of the tether 30 at connection 75, and the coil 70 may comprise a resilient structure such as a metal wire formed of any of the materials described with reference to stent 20. Coil 70 may be delivered via a lumen (e.g. guide wire lumen) extending through the lead 10 and is particularly suitable for an
OTW lead. The coil 70 may be advanced through the lumen of the lead 10 using a push tube (not shown) having sufficient column strength disposed over the tether 30 that abuts the connection 75 between the coil 70 and the tether 30. [048] To accommodate delivery through the lumen extending through the lead 10, the coil 70 may have a delivery configuration wherein the coil 70 is elongated to have a reduced profile sufficiently small to fit into the lumen, and a deployed configuration wherein the coil 70 is radially expanded to have an expanded profile sufficiently large to frictionally engage the wall of the CN. The coil 70 may be highly elastic such that it assumes the deployed configuration automatically upon advancement out of the distal end of the lead 10, or the coil may be actuated (e.g., thermally) upon advancement out of the distal end of the lead 10 to assume the deployed configuration. [049] With reference to Figure 8, an alternative anchor device arrangement is shown schematically. In this embodiment, a bundle 80 is deployed distal of the lead 10 and connected via tether 30 to lead 10 as described with reference to Figure 3. The proximal end of the bundle 80 may be connected to the distal end of the tether 30 at connection 85, and the bundle 80 may comprise a resilient structure such as a metal wire formed of any of the materials described with reference to stent 20. Bundle 80 may be delivered in the same manner as and may have the same or similar characteristics as coil 70 described with reference to Figure 7. Bundle 80, as opposed to coil 70, may have an occlusive effect, and therefore may be particularly suitable for a SCN to take advantage of collateral venous circulation. [050] With reference to Figure 9, an alternative anchor device arrangement is shown schematically. This embodiment is similar to the embodiment illustrated in Figure 5, except that a plug 90 is used in place of stent 20. The plug 90 may comprise a curable adhesive (e.g., cyanoacrylate, EN A in a DSMO solvent) or an embolic coil, for example, such as those conventionally used in occluding blood vessels and aneurisms. Plug 90 may be deployed in a SCN using a conventional embolic delivery system and connected via tether 30 and collar 40 to lead 10 as described with reference to Figure 4. Positioning the plug 90 in a SCN enhances the anchoring effect, and despite the occlusive effect of the plug 90, the possibility of adverse effects are reduced if not eliminated due to collateral venous circulation. [051] With reference to Figures 10 and 11, alternative anchor device arrangements are shown schematically. In these embodiments, a wedge 140 or 150 is deployed adjacent the distal portion of the lead 10, such as proximal of electrodes 14. Wedges 140 and 150 frictionally engage the lead body 12 and the wall of the CN, to lodge the lead 10 in the desired position in the CN. The wedges 140 and 150 may be connected to tether 30 to facilitate subsequent removal. Wedges 140 and 150 may comprise any of the materials discussed with reference to stent 20. [052] Wedges 140 and 150 are particularly suitable for deployment after the lead 10 has been delivered to the desired position, as shown in Figures 10 and 11. Alternatively, the wedges 140 and 150 may be deployed before the lead 10 has been delivered, with the wedges positioned distally of the desired position for the lead 10. In this alternative embodiment, the wedge may be over-sized with respect to the inside diameter of the CN where it is to be positioned in order to cause atraumatic expansion of the CN wall around the wedge, thus enhancing friction therebetween. [053] With specific reference to Figure 10, wedge 140 includes a body portion 142 and optional threads 144. Body portion 142 may include a perfusion lumen extending therethrough to permit blood perfusion from the distal end to the proximal end of the wedge 140. The wedge body 142 (or the wedge threads 144 if used) may have a diameter slightly greater than the diameter of the lumen of the CN less the diameter of the lead 10 in order to provide a snug frictional fit therebetween. Wedge 140 may be delivered into the desired position utilizing a push tube 60 advanced over a guide wire (not shown), for example, wherein the push tube 60 has sufficient column strength to push the wedge 140 alongside the lead 10 with the distal end 65 of the push tube abutting the proximal end of the wedge 140 and the tether 30 extending through the push tube. The push tube may also have sufficient torsional strength with a distal end 65 that mates with the proximal inside diameter of the wedge 140 such that the wedge 140 may be rotated to engage or disengage the threads 144 with the lead 10 and the wall of the CN. [054] With specific reference to Figure 11, wedge 150 comprises a short dual lumen having one lumen to accommodate the lead 10 and another (crescent shaped) lumen to permit blood perfusion from the distal end to the proximal end of the wedge 150. The wedge 150 may be tapered and may have a diameter slightly greater than the diameter of the lumen of the CN less the diameter of the lead 10 in order to provide a snug frictional fit therebetween. Stepped ridge 45 prevents proximal movement of the lead 10 relative to wedge 150 as described previously. Wedge 150 may be delivered into the desired position utilizing a push tube 50 advanced over the lead 10, as described previously. [055] With reference to Figure 12, a cutting device 160 is shown schematically. Cutting device 160 may be used to cut tether 30 and/or stop 35 in order to disconnect the tether 30 from the anchor device, such as stent 20. Cutting device 160 is merely an example of a variety of cutting mechanisms that may be used to sever the connection of the tether 30 from the anchor device. For example, the tether 30 may be equipped with two internal wires connected to a distal electrolytic fuse that separates (melts) upon the application of electrical current, such as those used for detachable embolic coils. [056] In this exemplary embodiment, cutting device 160 includes an outer tube 162 and an inner tube 164 coaxially disposed and movable therein. The outer and inner tubes 162 and 164 may have a length sufficient to extend from outside the vascular access site to the anchor device, and may be configured for intravascular navigation and advancement over tether 30. The distal end of the inner tube 164 may have a sharpened edge and may be formed of a material that retains a cutting edge (e.g., metal). A cutting hole 168 is provided adjacent the distal end of the outer tube 162 through which the tether 30 may be threaded. The distal circumference of the cutting hole 168 may be sharpened and may be formed of a material that retains a cutting edge (e.g., metal) After the cutting device is advanced over the tether 30 to the desired cutting site, the inner tube 164 may be advanced distally as indicated by arrow 166, with the sharpened distal end of the inner tube 164 and the sharpened cutting hole 168 acting as shears to cut the tether 30 at the cutting hole 168. [057] With reference to Figure 13, a lead 10 is shown disposed in a CN, with an anchor device in the form of a coiled stent 200 disposed near the ostium of the CS. The coiled stent 200 may be positioned near the ostium of the CS, where the vessel diameter is large enough to resist becoming occluded by the presence of the coiled stent 200 next to the lead 10. However, it is contemplated that the coiled stent 200 may be placed elsewhere within the CS or CN in which the lead is positioned. As seen in Figure 13 A, the lead 10 is eccentrically disposed in the lumen of the CS to define a relatively large crescent shaped blood perfusion lumen. [058] Coil stent 200 may be formed of a resilient material such as Νitinol, Elgiloy, MP35Ν, or stainless steel. Coiled stent 200 could also be formed of degradable materials such as those described in reference to stent 20 above. Coiled stent 200 may be releasably attached to the lead 10 utilizing collar 210, and collar 210 may frictionally engage the body 12 of lead 10, thus facilitating anchoring of the lead within the coronary sinus or cardiac vein. [059] With reference to Figure 13B, the collar 210 may comprise a relatively short tube 212, and may include one or more proximally oriented grips 218. Grips 218 may be in the shape of finger-like projections, or circular ribs either partially or completely extending circumferentially around the inside of tube 212. Grips 218 facilitate the advancement of the collar 210 in a distal direction for delivery over lead 10, but resist proximal movement once the collar 210 is positioned in a desired anchoring location. Grips 218 may be formed of a soft resilient material such as silicone, polyurethane, polyether- block-amide, or the like. [060] To facilitate subsequent removal of the lead 10, the coiled stent 200 may be connected to the collar 210 in a detachable manner. For example, the coiled stent 200 may be connected to the collar 210 utilizing a biodegradable adhesive connecting adjacent portions of the coil 200 to the collar 210. Such an adhesive may degrade after the lead 10 has chronically anchored to the wall of the CS by normal tissue encapsulation. After the adhesive has degraded, the lead 10 (along with collar 210) may be removed utilizing standard techniques, with the coiled stent 200 remaining in the CS. [061] Alternatively, the coiled stent 200 may be secured to the collar 210 utilizing a retractable pin 220. In this alternative embodiment, collar 210 may include two angled flanges 214 collectively defining a recess 216 in which stent coil 200 may reside. Pin 220 may span the length of the recess 216 between the flanges 214, extending over the coiled stent 200 to retain the coil stent 200 in the recess 216, thus providing a connection between the stent coil 200 and the collar 214. Subsequent release of the stent coil 200 from the lead 10 may be accomplished by removing pin 220 using tether 30 which extends from the proximal end of the lead 10 to the pin 220. The proximal end of the pin 220 is connected to the distal end of the tether 30, and the pin 220 may be removed by pulling the tether 30 proximally. After the pin 220 is removed, the lead 10 and collar 210 are free from the stent coil 200 and may be removed with standard techniques, leaving stent coil 200 in the CS. [062] Delivery and deployment of the stent coil 200 and collar 210 may be facilitated by deployment sheath 230. The deployment sheath 230 may comprise a tubular catheter, having a lumen extending therethrough to accommodate the lead 10 and the stent coil 200. Alternatively, the lumen in the deployment sheath 230 may extend from a distal opening to a mid-shaft opening as used in conventional monorail style balloon catheters. After lead 10 has been positioned by standard techniques to a desired position, the stent coil 200 and collar 210 may be loaded on the proximal end of the lead 10. Coil 200 may be initially in a compressed condition, and loaded in the inside of the deployment sheath 230. If the lead 10 has a large diameter proximal connector, an optional slit 215 may be provided in the collar 220 to facilitate loading over the large diameter connector. In this case, the collar 210 and coil 200 may be positioned on the lead body 12 before the coil 200 is loaded into the deployment sheath 230. The deployment sheath 230 may be advanced distally down the body 12 of the lead 10 until the stent coil 200 and collar 210 are in the desirable location. The deployment sheath 230 may then be withdrawn proximally, with the collar 210 and stent coil 200 remaining in position on the lead 10 due to grips 218 on collar 210. As the stent coil 200 emerges from the deployment sheath 230, it expands to engage the wall of the CS. The deployment sheath 230 can then be removed from the lead 10. [063] Figures 14 and 15 illustrate an anchor device in the form of an anchoring catheter 300, which may be utilized to secure the position of lead 10, particularly during the removal of the guide sheath (guide catheter) used in the delivery of the lead 10. As described above, the lead stability is particularly vulnerable during the removal of the guide sheath. [064] In use, the anchoring catheter 300 is positioned next to the lead 10 after lead 10 has been positioned in a desired location. Anchoring catheter 300 may be advanced within the guide sheath (not shown), generally parallel to the lead body 12, or may be advanced outside the guide sheath. An expandable member such as a balloon 314 is inflated to frictionally secure lead 10 against the wall of the blood vessel. The guide sheath can then be removed without inadvertent dislodgement of the lead 10. The anchoring catheter 300 can then be removed. Since anchoring catheter 300 is next to and not surrounding the lead body 12, removal of the anchoring catheter 300 does not pose a risk of dislodging lead 10. [065] With particular reference to Figure 15, anchoring catheter 300 is shown in more detail. Shaft 312 may comprise a proximal shaft portion 312A connected by adhesive, for example, to a distal shaft portion 312B. A luer adaptor 316 may be connected to the proximal end of the proximal shaft portion 312A for connection to an inflation apparatus (not shown) such as a syringe. An inflatable balloon 314 may be connected to the distal end of the distal shaft portion 312B, and may be formed of elastomeric material or a molded inelastic material. [066] Proximal shaft portion 312A may be relatively stiff and may be formed of a metallic tube such as a stainless steel hypotube. Distal shaft portion 312B may be relatively flexible and may be formed of a polymeric tube, for example. To facilitate advancement of the flexible distal shaft portion 312B and the balloon 314, a core wire may be connected to and extend from the distal end of the proximal shaft portion 312A. The core wire 320 may comprise a metal wire such as a tapered stainless steel mandrel. [067] Core wire 320 extends to the distal end of the balloon 314, and may extend beyond with an atraumatic spring tip, for example. The distal end of the balloon 314 may be bonded to the core wire 320, and the proximal end of the balloon 314 may be bonded to the distal end of the distal shaft portion 312B. Within the shaft 312 is a lumen through which inflation medium is infused to inflate balloon 314. [068] With general reference to Figures 16A - 16E, various embodiments of retrievable anchor devices are shown in expanded state. These retrievable (i.e., repositionable and/or removable) designs are similar to the self-expanding stent anchor embodiment described with reference to Figures 3 and 6, the general aspects of which may be applied hereto. In each of the illustrated embodiments, the self-expanding anchor 20 is configured to be collapsed and retracted into a retrieval tube 128 (similar to outer tube 120) by pulling proximally on the tether 30 and/or by pushing distally on the retrieval tube 128. Alternatively, a pull chord (not shown) separate from the tether 30 may be used to collapse and retract the anchor 20 into the retrieval tube 128. In this alternative embodiment, the pull chord may be connected to a proximal end of the anchor 20 and the tether 30 may be connected to the anchor 20 distal of the proximal end thereof. The retrieval tube 128 may have a distal inside taper or funnel shape to facilitate collapse of the self-expanding anchor 20 when pulled therein. [069] With specific reference to Figure 16A, the retrievable anchor 20 may comprise a self-expanding braided structure 20 A. The braided structure 20A is expanded in its relaxed state and may be compressed to fit into the delivery tube 120 or retrieval tube 128. The braided anchor 20 A may include a plurality (e.g., eight or more) of highly flexible and elastic elongate members formed of a metal (e.g., stainless steel, Nitinol, Elgiloy, or MP35N), for example, that cross over and under each other in a braid pattern. The distal ends of the elongate members may be fused in pairs and/or shaped to face inwardly to provide an atraumatic distal edge. The proximal ends of the elongate members may be connected to the tether 30 to facilitate collapse and retraction into the retrieval tube 128. [070] With reference to Figures 16B and 16C, the retrievable anchor
20 may comprise a self-expanding snare-like structure 20B or a self-expanding stone basket-like structure 20C, respectively. The snare-like 20B or basket-like 20C structures may include a plurality (e.g., two or more) of highly flexible and elastic elongate members formed of a metal (e.g., stainless steel, Nitinol, Elgiloy, or MP35N), for example, that extend generally parallel, do not cross, and bow outwardly. The snare-like 20B or basket-like 20C structures are expanded in their relaxed state and may be compressed to fit into the delivery tube 120 or retrieval tube 128. The distal ends of the elongate members may be fused together to provide an atraumatic distal tip, and the proximal ends of the elongate members may be connected to the tether 30 to facilitate collapse and retraction into the retrieval tube 128. [071] With reference to Figure 16D, the retrievable anchor 20 may comprise a self-expanding stent 20D formed of a cut super elastic hypotube, for example. The self-expanding stent 20D is expanded in its relaxed state and may be compressed to fit into the delivery tube 120 or retrieval tube 128. The self-expanding stent 20D may be laser cut from a metallic (e.g., stainless steel, Nitinol, Elgiloy, or MP35N) hypotube, for example, having almost any desired pattern. In the illustrated embodiment, the self-expanding stent 20D has two sets of four diamonds interconnected by four middle struts. The proximal set of four diamonds provide a four point crown, to which a parachute-like tether 30 may be connected to facilitate collapse and retraction into the retrieval tube 128. [072] With reference to Figure 16E, the retrievable anchor 20 may comprise a self-expanding stent 20E having a proximal taper. This stent 20E is similar to the stent 20D described above with the exception of the proximal taper. The proximal taper on the stent 20E shown in Figure 16E serves a similar function as the parachute-like tether 30 shown in. Figure 16D, but provides for a single attachment point for the tether 30. The tether 30 is connected to the proximal end of the tapered portion of the stent to facilitate collapse and retraction into the retrieval tube 128. The attachment point (i.e., tip) of the proximal taper may be concentric with the remainder of the structure as shown, or may be eccentric. An eccentric arrangement may promote more effective capture by biasing the tether 30 against the wall of the CN to thereby urge the lead electrode 14 against the CN wall. [073] Figure 17A illustrates in more detail an example of a self- expanding stent 20E having a proximal taper. In this example, the stent 20E may be formed from Nitinol tubing commercially available from Nitinol Devices & Components, Inc. (NDC) with an inside diameter of approximately 0.024 inches and an outside diameter of 0.032 inches (NDC stock SE508). The tubing, the outer surface of which is shown in an unrolled state only for purposes of illustrating the pattern, may be cut into the desired pattern using laser cutting techniques employed by Laserage, Inc., for example. The pattern shown may have the following dimensions (inches): LI = 0.150; L2 = 0.050; L3 - 0.150; L4 = 0.150; L5 = 0.150; A = 0.100; B = 0.0075; C = 0.0075; D = 0.005; E = 0.0175; Rl = 0.0025; and R2 = 0.010. [074] After the desired pattern has been cut into the tube, the tube may be expanded into a stent 20E having an outside diameter of approximately 0.180 to 0.200 inches, for example. To effect expansion into the desired shape, the cut tubing may be placed on sequentially larger (e.g., steps of 0.030 inches) forming mandrels and briefly (e.g., 60 seconds) exposed to 500 C. The formed tubing may be given its final shape set for 4 minutes at 550 C, and then may be aged at 470 C. to provide a stent that has a martensite to austenite transformation which occurs over a relatively narrow temperature range (e.g. 15 centigrade degrees). After expanding and heat treating the cut tubing into a formed stent 20E, the stent may be grit-blasted and electro-polished to improve the mechanical integrity of the stent and smooth sharp edges. [075] An example of a formed stent 20E is schematically shown in
Figures 17B and 17C, which illustrate top and side views respectively, with the proximal end (for comiection to the tether) shown to the left and the distal end shown to the right. As seen in Figure 17B, the proximal portion of the stent 20E has a tapered structure to facilitate collapse of the stent 20E into a lumen of a delivery catheter (for removal or repositioning of the stent 20E) by pulling on the tether relative to the catheter. As seen in Figure 17C, the proximal end of the stent 20E may be eccentrically disposed such that the tether and thus the lead electrodes lie against and establish good electrical contact with vascular or myocardial tissue. [076] All dimension of the stent 20E may be modified from the specific embodiment illustrated. For example, to avoid interference with lead placement, the stent 20E may have a length less than 1.0 inches, or less than 0.50 inches. To improve frictional anchoring by over-sizing, the stent anchor 20E may have an expanded diameter of preferably approximately 125% to 200% the inside diameter of the CN where the stent 20E is to be deployed. [077] Figures 18 A and 18B illustrate how a metallic anchor may be connected to a lead body and used as a pacing electrode. For sake of illustration, the anchor is shown to be a self-expanding stent anchor 20E with a proximal tapered portion to facilitate removal. All aspects of the anchor devices described with reference to Figures 3, 6 and 16A - 16E may be applied to these embodiments. In the illustrated embodiments, the anchor may comprise a metallic structure to serve as an electrode and may be electrically connected to the conductors in the lead. Electrical contact between the anchor and the lead conductors may be provided internal to the lead as shown in Figure 18A or external to the lead as shown in Figure 18B. [078] With specific reference to Figure 18 A, the lead 10 may be modified to have internal electrical contacts 16 exposed to the guide wire lumen and electrically connected to wires extending proximally in the lead body 12. The stent anchor 20E may have a proximally disposed electrical contact 24 that is electrically connected to all or a select portion of the stent structure. The electrical contacts 16 are configured to electrically and mechanically engage with electrical contact 24 such that when the lead 10 is advanced distally, the internal electrical contacts 16 engage the stent contact 24 to establish electrical connection and mechanical lock. Because the stent anchor 20E serves as the pacing electrode, the conventional outer electrodes 14 on the lead may optionally be eliminated. [079] With reference to Figure 18B, the conventional lead electrode(s) 14 establish direct contact with the inside of the stent structure 20E to provide and electrical connection therebetween. To facilitate this arrangement, the tether 30A may be connected to a distal strut of the stent structure 20E, extend inside the stent lumen, and pass through the guide wire lumen of the lead 10. With this arrangement, when the lead 10 is advanced distally, the lead electrode(s) 14 engage the exposed metallic stent structure 20Eto establish electrical connection therebetween. To facilitate removal, a pull chord 3 OB may be connected to the proximal tip of the tapered portion of the stent anchor 20E. [080] Figure 19 illustrates an alternative anchor delivery catheter device 100, similar to the delivery device described with reference to Figure 6. The delivery catheter 100 includes an inner tube 110 which extends through an outer tube 120. The inner tube 110 may include a guide wire lumen portion 112 and a coextending tether lumen portion 114. The inner tube may comprise a dual lumen extrusion or two tubes secured side-by-side, for example. The guide wire lumen portion 112 of the inner tube may be configured to contain a guide wire 130 extending therethrough. The tether lumen portion 114 of the inner tube may be configured to contain the tether 30 extending therethrough. [081] Stent anchor 20E is shown in a compressed condition inside the delivery catheter 100. Outer tube 120 maintains the stent anchor 20E in its compressed condition while the delivery catheter 100 is advanced to the desired site within the cardiac vasculature for deployment. [082] The guide wire lumen portion 112 may extend inside the compressed anchor 20E, and the tether lumen portion 114 may extend up to the proximal end of the stent anchor 20E adjacent the attachment point of the tether 30. A transition member 116 may be provided at or near the distal end of the guide wire lumen portion 112, which serves to diametrically transition the guide wire lumen portion 112 with the outer tube 120. [083] As depicted, prior to deployment of the anchor 20E, the proximal end of the inner tube 110 extends proximal of the proximal end of the outer tube 120. When it is desired to deploy anchor 20E, the outer tube 120 may retracted proximally relative to the inner tube 110, allowing the compressed anchor 20E to expand. After the anchor 20E is deployed, the outer tube 120 and inner tube 110 are withdrawn proximally (as well as the guide wire 130 if desired) relative to the anchor 20E and the tether 30, thus leaving the anchor 20E is place where deployed, with the tether 30 trailing behind. [084] When it is desired to advance an over-the-wire lead 10 over the tether 30 and into the vasculature, a leader 36 may be connected to the tether 30 by a connection mechanism. An example of a connection mechanism includes a tubular female receptacle 34, which mates with a male insert 32. Male insert 32 preferably includes curved regions that serve to increase the frictional engagement after the male insert 32 is position within the female receptacle 34. Other suitable comiection mechanisms include those used for extending angioplasty guide wires, for example. After the lead 10 has been positioned in a desired portion of the vasculature, the connection 32/34 will be positioned proximal to the proximal end of the lead, and the connection 32/34 can thereafter be disconnected if desired. [085] Those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.

Claims

What is claimed is:
1. A device for stabilizing a lead in a coronary vessel, comprising: an intravascular anchor; and a releasable connector connecting the anchor to the lead, the connector configured to permit independent delivery of the anchor and the lead.
2. A device as in claim 1, wherein the connector configured to permit independent positioning of the anchor and the lead
3. A device as in claim 2, wherein the comiector comprises an elongate member.
4. A device as in claim 3, wherein the lead includes a lumen extending therethrough, and wherein the elongate member is sized to extend through the lead lumen.
5. A device as in claim 3, further comprising a fastener connected to the lead, wherein the elongate member is connected to the fastener.
6. A device as in claim 2, wherein the lead includes a lumen extending therethrough, and wherein the anchor is sized to be delivered through the lead lumen.
7. A device as in claim 2, wherein the anchor comprises an expandable structure.
8. A device as in claim 7, wherein the anchor comprises a stent.
9. A device as in claim 7, wherein the anchor comprises an occlusion device.
10. A device as in claim 2, wherein the anchor comprises an expandable structure extending around the lead.
11. A device as in claim 10, wherein the connector comprises a collar disposed on the lead and connected to the anchor.
12. A system for stabilizing a lead in a cardiac vein, comprising: a lead; and an anchor device configured for independent delivery from the lead, the anchor device configured to be releasably engaged with the lead to stabilize the lead in the cardiac vein.
13. A system as in claim 12, wherein the anchor device is frictionally engageable with the lead.
14. A system as in claim 12, wherein the anchor device is engageable with the lead by a connector.
15. A method for stabilizing a lead in a cardiac vein, comprising: providing a lead; delivering the lead into a cardiac vein; providing an anchor device capable of independent delivery from the lead; delivering the anchor device into the cardiac vein; and releasably engaging the anchor device with the lead to stabilize the lead with respect to the cardiac vein.
16. A method as in claim 15, wherein the step of delivering the anchor device into the cardiac vein adjacent the lead comprises positioning the anchor device distal of the lead.
17. A method as in claim 15, wherein the step of delivering the anchor device into the cardiac vein adjacent the lead comprises positioning the anchor device side-by-side with the lead.
18. A method as in claim 15, wherein the step of stabilizing the lead with respect to the cardiac vein comprises engaging the anchor device with the lead.
19. A method as in claim 18, wherein the step of engaging the anchor device with the lead comprises connecting the anchor device to the lead with a connector.
20. A method as in claim 18, wherein the step of engaging the anchor device with the lead comprises frictionally engaging the anchor device with the lead.
21. A device as in claim 1 , wherein the anchor comprises a biodegradable material.
22. A device as in claim 1, wherein the anchor is configured to be removable.
23. A device as in claim 1, wherein the connector is releasable from the anchor.
24. A device as in claim 1, wherein the connector is releasable from the lead.
25. A system as in claim 12, wherein the anchor device comprises a biodegradable material.
26. A system as in claim 12, wherein the anchor device is configured to be removable.
27. A system as in claim 14, wherein the connector is releasable from the anchor.
28. A system as in claim 14, wherein the connector is releasable from the lead.
PCT/US2004/033156 2003-10-10 2004-10-08 Lead stabilization devices and methods WO2005053784A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP04794493A EP1722847A4 (en) 2003-10-10 2004-10-08 Lead stabilization devices and methods
US11/139,894 US7797053B2 (en) 2003-10-10 2005-05-27 Lead stabilization devices and methods

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US51066303P 2003-10-10 2003-10-10
US60/510,663 2003-10-10
US10/736,863 2003-12-16
US10/736,863 US20050080472A1 (en) 2003-10-10 2003-12-16 Lead stabilization devices and methods
US57636804P 2004-06-02 2004-06-02
US60/576,368 2004-06-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/736,863 Continuation-In-Part US20050080472A1 (en) 2003-10-10 2003-12-16 Lead stabilization devices and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/139,894 Continuation US7797053B2 (en) 2003-10-10 2005-05-27 Lead stabilization devices and methods

Publications (2)

Publication Number Publication Date
WO2005053784A2 true WO2005053784A2 (en) 2005-06-16
WO2005053784A3 WO2005053784A3 (en) 2006-10-19

Family

ID=35542386

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/033156 WO2005053784A2 (en) 2003-10-10 2004-10-08 Lead stabilization devices and methods

Country Status (3)

Country Link
US (2) US20050080472A1 (en)
EP (1) EP1722847A4 (en)
WO (1) WO2005053784A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008095671A2 (en) 2007-02-07 2008-08-14 Creganna Technologies Limited Method of making cobalt-based alloy tubes having enhanced mechanical performance characteristics and a tube formed by the method
WO2009042250A1 (en) 2007-09-26 2009-04-02 Cardiac Pacemakers, Inc. Left-ventricular lead fixation device in coronary veins
WO2009158444A1 (en) * 2008-06-27 2009-12-30 Medtronic, Inc. Lead delivery device and method
US7865249B2 (en) 2006-09-22 2011-01-04 Cardiac Pacemakers, Inc. Means to securely fixate pacing leads and/or sensors in vessels
US9480839B2 (en) 2002-09-24 2016-11-01 Medtronic, Inc. Lead delivery device and method
US9636499B2 (en) 2002-09-24 2017-05-02 Medtronic, Inc. Lead delivery device and method
US9713709B2 (en) 2002-09-24 2017-07-25 Medtronic, Inc. Lead delivery device and method
US9775989B2 (en) 2008-06-27 2017-10-03 Medtronic, Inc. Lead delivery device and method
US9775990B2 (en) 2008-06-27 2017-10-03 Medtronic, Inc. Lead delivery device and method
US11931523B2 (en) 2008-06-27 2024-03-19 Medtronic, Inc. Lead delivery device and method

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7617007B2 (en) * 2003-06-04 2009-11-10 Synecor Llc Method and apparatus for retaining medical implants within body vessels
US8239045B2 (en) * 2003-06-04 2012-08-07 Synecor Llc Device and method for retaining a medical device within a vessel
JP4616252B2 (en) * 2003-06-04 2011-01-19 シネコー・エルエルシー Intravascular electrophysiology system and method
US7082336B2 (en) 2003-06-04 2006-07-25 Synecor, Llc Implantable intravascular device for defibrillation and/or pacing
WO2005058415A2 (en) * 2003-12-12 2005-06-30 Synecor, Llc Implantable medical device having pre-implant exoskeleton
WO2005067817A1 (en) 2004-01-13 2005-07-28 Remon Medical Technologies Ltd Devices for fixing a sensor in a body lumen
WO2005077450A2 (en) * 2004-02-10 2005-08-25 Synecor, Llc Intravascular delivery system for therapeutic agents
US20060122522A1 (en) * 2004-12-03 2006-06-08 Abhi Chavan Devices and methods for positioning and anchoring implantable sensor devices
US10390714B2 (en) * 2005-01-12 2019-08-27 Remon Medical Technologies, Ltd. Devices for fixing a sensor in a lumen
US7962208B2 (en) 2005-04-25 2011-06-14 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US7330765B2 (en) * 2005-04-25 2008-02-12 Cardiac Pacemakers, Inc. Cardiac lead having self-expanding fixation features
US7477946B2 (en) * 2005-04-26 2009-01-13 Cardiac Pacemakers, Inc. Fixation device for coronary venous lead
US8175724B2 (en) * 2005-04-26 2012-05-08 Cardiac Pacemakers, Inc. Vascular fixation device
US20070100414A1 (en) 2005-11-02 2007-05-03 Cardiomind, Inc. Indirect-release electrolytic implant delivery systems
US20070106358A1 (en) * 2005-11-04 2007-05-10 Cardiac Pacemakers, Inc. Tissue stimulating lead and method of implantation and manufacture
US8060214B2 (en) * 2006-01-05 2011-11-15 Cardiac Pacemakers, Inc. Implantable medical device with inductive coil configurable for mechanical fixation
US7616992B2 (en) * 2006-01-30 2009-11-10 Medtronic, Inc. Intravascular medical device
US7627376B2 (en) * 2006-01-30 2009-12-01 Medtronic, Inc. Intravascular medical device
US8532789B2 (en) * 2006-02-28 2013-09-10 Medtronic, Inc. Subcutaneous lead fixation mechanisms
US8406901B2 (en) 2006-04-27 2013-03-26 Medtronic, Inc. Sutureless implantable medical device fixation
US7865248B2 (en) * 2006-06-15 2011-01-04 Cardiac Pacemakers, Inc. Biasing and fixation features on leads
US20080071315A1 (en) * 2006-08-31 2008-03-20 Tamara Colette Baynham Integrated catheter and pulse generator systems and methods
US20080071248A1 (en) * 2006-09-15 2008-03-20 Cardiac Pacemakers, Inc. Delivery stystem for an implantable physiologic sensor
ES2369203T3 (en) 2006-09-15 2011-11-28 Cardiac Pacemakers, Inc. ANCHORAGE FOR AN IMPLANTABLE MEDICAL DEVICE.
US8676349B2 (en) 2006-09-15 2014-03-18 Cardiac Pacemakers, Inc. Mechanism for releasably engaging an implantable medical device for implantation
US9492657B2 (en) 2006-11-30 2016-11-15 Medtronic, Inc. Method of implanting a medical device including a fixation element
US20080147168A1 (en) * 2006-12-04 2008-06-19 Terrance Ransbury Intravascular implantable device having detachable tether arrangement
US8311633B2 (en) * 2006-12-04 2012-11-13 Synecor Llc Intravascular implantable device having superior anchoring arrangement
US20080154326A1 (en) * 2006-12-21 2008-06-26 Clyne Christopher A Method and apparatus for providing a radiopaque anchoring sleeve
US7662132B2 (en) * 2007-01-25 2010-02-16 Cardiac Pacemakers, Inc. Expandable member for venous lead fixation
US20080183187A1 (en) * 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Direct delivery system for transvascular lead
US8244378B2 (en) * 2007-01-30 2012-08-14 Cardiac Pacemakers, Inc. Spiral configurations for intravascular lead stability
US7917230B2 (en) * 2007-01-30 2011-03-29 Cardiac Pacemakers, Inc. Neurostimulating lead having a stent-like anchor
US7949409B2 (en) * 2007-01-30 2011-05-24 Cardiac Pacemakers, Inc. Dual spiral lead configurations
US20080183264A1 (en) * 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Electrode configurations for transvascular nerve stimulation
US20080183255A1 (en) * 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Side port lead delivery system
US20080183265A1 (en) * 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Transvascular lead with proximal force relief
US11679262B2 (en) 2007-03-09 2023-06-20 Mainstay Medical Limited Systems and methods for restoring muscle function to the lumbar spine
EP2125100B1 (en) 2007-03-09 2021-08-25 Mainstay Medical Limited Muscle stimulator
US9072897B2 (en) 2007-03-09 2015-07-07 Mainstay Medical Limited Systems and methods for restoring muscle function to the lumbar spine
US11331488B2 (en) 2007-03-09 2022-05-17 Mainstay Medical Limited Systems and methods for enhancing function of spine stabilization muscles associated with a spine surgery intervention
US10925637B2 (en) * 2010-03-11 2021-02-23 Mainstay Medical Limited Methods of implanting electrode leads for use with implantable neuromuscular electrical stimulator
US11679261B2 (en) 2007-03-09 2023-06-20 Mainstay Medical Limited Systems and methods for enhancing function of spine stabilization muscles associated with a spine surgery intervention
US8000810B2 (en) * 2007-03-20 2011-08-16 Cardiac Pacemakers, Inc. Systems and methods for transvenous lead implantation
US8204599B2 (en) 2007-05-02 2012-06-19 Cardiac Pacemakers, Inc. System for anchoring an implantable sensor in a vessel
US7634318B2 (en) 2007-06-14 2009-12-15 Cardiac Pacemakers, Inc. Multi-element acoustic recharging system
US20110106120A1 (en) * 2008-01-18 2011-05-05 Med Institute, Inc. Intravascular device attachment system having tubular expandable body
US8694128B2 (en) * 2008-01-25 2014-04-08 Medtronic, Inc. Medical electrical lead
US9242100B2 (en) 2012-08-07 2016-01-26 Nuax, Inc. Optical fiber-fine wire lead for electrostimulation and sensing
US9193313B2 (en) 2012-03-22 2015-11-24 Nuax, Inc. Methods and apparatuses involving flexible cable/guidewire/interconnects
US9513443B2 (en) 2008-05-28 2016-12-06 John Lawrence Erb Optical fiber-fine wire conductor and connectors
US9025598B1 (en) 2012-03-22 2015-05-05 Nuax, Inc. Cable/guidewire/interconnects communication apparatus and methods
US8692117B2 (en) 2008-05-28 2014-04-08 Cardia Access, Inc. Durable fine wire electrical conductor suitable for extreme environment applications
US9409012B2 (en) * 2008-06-19 2016-08-09 Cardiac Pacemakers, Inc. Pacemaker integrated with vascular intervention catheter
US8457738B2 (en) * 2008-06-19 2013-06-04 Cardiac Pacemakers, Inc. Pacing catheter for access to multiple vessels
US20090318749A1 (en) * 2008-06-19 2009-12-24 Craig Stolen Method and apparatus for pacing and intermittent ischemia
US9037235B2 (en) 2008-06-19 2015-05-19 Cardiac Pacemakers, Inc. Pacing catheter with expandable distal end
US20090318994A1 (en) * 2008-06-19 2009-12-24 Tracee Eidenschink Transvascular balloon catheter with pacing electrodes on shaft
US8639357B2 (en) * 2008-06-19 2014-01-28 Cardiac Pacemakers, Inc. Pacing catheter with stent electrode
US8244352B2 (en) * 2008-06-19 2012-08-14 Cardiac Pacemakers, Inc. Pacing catheter releasing conductive liquid
US20090318984A1 (en) * 2008-06-19 2009-12-24 Mokelke Eric A External pacemaker with automatic cardioprotective pacing protocol
US8126571B2 (en) * 2008-06-23 2012-02-28 Cardiac Pacemakers, Inc. Expandable assembly for cardiac lead fixation
WO2010008936A1 (en) 2008-07-15 2010-01-21 Cardiac Pacemakers, Inc. Implant assist apparatus for acoustically enabled implantable medical device
US20100056858A1 (en) * 2008-09-02 2010-03-04 Mokelke Eric A Pacing system for use during cardiac catheterization or surgery
EP3714771A1 (en) 2008-10-01 2020-09-30 Inspire Medical Systems, Inc. System for treating sleep apnea transvenously
US9108025B2 (en) * 2008-10-09 2015-08-18 Gardia Medical Ltd. Apparatus and method for anchoring an elongated object in body lumens
US20100191168A1 (en) 2009-01-29 2010-07-29 Trustees Of Tufts College Endovascular cerebrospinal fluid shunt
US8694129B2 (en) * 2009-02-13 2014-04-08 Cardiac Pacemakers, Inc. Deployable sensor platform on the lead system of an implantable device
JP2012521864A (en) 2009-03-31 2012-09-20 インスパイア・メディカル・システムズ・インコーポレイテッド Percutaneous access method in a system for treating sleep-related abnormal breathing
US20100318166A1 (en) * 2009-06-12 2010-12-16 Terrance Ransbury Methods and systems for anti-thrombotic intravascular implantable devices
US20110004288A1 (en) * 2009-06-12 2011-01-06 Terrance Ransbury Intravascular implantable device having integrated anchor mechanism
US20110106099A1 (en) * 2009-10-29 2011-05-05 Medtronic, Inc. Lead extraction device
US9950159B2 (en) 2013-10-23 2018-04-24 Mainstay Medical Limited Systems and methods for restoring muscle function to the lumbar spine and kits for implanting the same
US11684774B2 (en) 2010-03-11 2023-06-27 Mainstay Medical Limited Electrical stimulator for treatment of back pain and methods of use
WO2011112773A2 (en) 2010-03-11 2011-09-15 Mainstay Medical, Inc. Modular stimulator for treatment of back pain, implantable rf ablation system and methods of use
US11786725B2 (en) 2012-06-13 2023-10-17 Mainstay Medical Limited Systems and methods for restoring muscle function to the lumbar spine and kits for implanting the same
US9999763B2 (en) 2012-06-13 2018-06-19 Mainstay Medical Limited Apparatus and methods for anchoring electrode leads adjacent to nervous tissue
WO2012019034A1 (en) * 2010-08-05 2012-02-09 Cardiac Pacemakers, Inc. System and method for securing a lead in a vessel
US8475372B2 (en) 2010-10-29 2013-07-02 Medtronic Vascular, Inc. Implantable medical sensor and fixation system
US8864676B2 (en) 2010-10-29 2014-10-21 Medtronic Vascular, Inc. Implantable medical sensor and fixation system
US9775982B2 (en) 2010-12-29 2017-10-03 Medtronic, Inc. Implantable medical device fixation
US10112045B2 (en) 2010-12-29 2018-10-30 Medtronic, Inc. Implantable medical device fixation
US8727996B2 (en) 2011-04-20 2014-05-20 Medtronic Vascular, Inc. Delivery system for implantable medical device
US8401643B2 (en) * 2011-05-17 2013-03-19 Medtronic Vascular, Inc. Implantable medical sensor and anchoring system
AU2012290152B2 (en) * 2011-08-02 2016-08-11 Mainstay Medical Limited Apparatus for anchoring electrode leads for use with implantable neuromuscular electrical stimulator
KR101241267B1 (en) * 2011-08-24 2013-03-15 신경민 Guide wire guide device
US10173069B2 (en) 2012-01-26 2019-01-08 Medtronic, Inc. Medical device fixation
US9833625B2 (en) 2012-03-26 2017-12-05 Medtronic, Inc. Implantable medical device delivery with inner and outer sheaths
US9220906B2 (en) 2012-03-26 2015-12-29 Medtronic, Inc. Tethered implantable medical device deployment
US9717421B2 (en) 2012-03-26 2017-08-01 Medtronic, Inc. Implantable medical device delivery catheter with tether
US9854982B2 (en) 2012-03-26 2018-01-02 Medtronic, Inc. Implantable medical device deployment within a vessel
US9339197B2 (en) 2012-03-26 2016-05-17 Medtronic, Inc. Intravascular implantable medical device introduction
US10485435B2 (en) 2012-03-26 2019-11-26 Medtronic, Inc. Pass-through implantable medical device delivery catheter with removeable distal tip
US9186501B2 (en) 2012-06-13 2015-11-17 Mainstay Medical Limited Systems and methods for implanting electrode leads for use with implantable neuromuscular electrical stimulator
US10195419B2 (en) 2012-06-13 2019-02-05 Mainstay Medical Limited Electrode leads for use with implantable neuromuscular electrical stimulator
US9351648B2 (en) 2012-08-24 2016-05-31 Medtronic, Inc. Implantable medical device electrode assembly
US9737696B2 (en) 2014-01-15 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
EP3094365B1 (en) 2014-01-15 2021-12-08 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
WO2016020846A1 (en) 2014-08-06 2016-02-11 Mainstay Medical Limited Electrode leads for use with implantable neuromuscular electrical stimulator
EP2992925B1 (en) * 2014-09-04 2022-09-07 BIOTRONIK SE & Co. KG Intravascular electrode lead and intravascular stimulation device including the same
US10471268B2 (en) 2014-10-16 2019-11-12 Mainstay Medical Limited Systems and methods for monitoring muscle rehabilitation
WO2016070147A1 (en) 2014-10-31 2016-05-06 Cerevasc, Llc Methods and systems for treating hydrocephalus
US9757574B2 (en) 2015-05-11 2017-09-12 Rainbow Medical Ltd. Dual chamber transvenous pacemaker
WO2017019564A1 (en) * 2015-07-24 2017-02-02 Route 92 Medical, Inc. Methods of intracerebral implant delivery
US11628281B2 (en) 2015-09-08 2023-04-18 Transit Scientific, LLC Exoskeleton devices for use with elongated medical instruments
JP6820612B2 (en) 2015-10-30 2021-01-27 セレバスク,インコーポレイテッド Hydrocephalus treatment system and method
US20200254249A1 (en) 2015-11-17 2020-08-13 Inspire Medical Systems, Inc. Microstimulation sleep disordered breathing (sdb) therapy device
US10327810B2 (en) 2016-07-05 2019-06-25 Mainstay Medical Limited Systems and methods for enhanced implantation of electrode leads between tissue layers
WO2018017981A1 (en) 2016-07-22 2018-01-25 Route 92 Medical, Inc. Endovascular interventions in neurovascular anatomy
US20180353279A1 (en) * 2016-12-05 2018-12-13 Daniel E. Walzman Exchange wire anchored by a self-expanding retrievable stent and method of use
US11406801B2 (en) 2017-10-27 2022-08-09 Transit Scientific, LLC Exoskeleton device with expandable section for scoring
EP3700441A4 (en) 2017-10-27 2021-07-28 Transit Scientific, LLC Exoskeleton device with expandable section for scoring
US11013900B2 (en) 2018-03-08 2021-05-25 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
US10874850B2 (en) 2018-09-28 2020-12-29 Medtronic, Inc. Impedance-based verification for delivery of implantable medical devices
US11331475B2 (en) 2019-05-07 2022-05-17 Medtronic, Inc. Tether assemblies for medical device delivery systems

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1919246C3 (en) * 1968-07-27 1981-07-30 Harmjanz, Dietrich, Prof. Dr.Med., 3101 Gross Hehlen Electrode arrangement for electrical stimulation of the right ventricle
FR2423231A1 (en) * 1978-04-19 1979-11-16 Synthelabo ENDOCAVITY CARDIAC STIMULATION PROBE
US4458677A (en) * 1979-09-19 1984-07-10 Mccorkle Jr Charles E Intravenous channel cardiac electrode and lead assembly and method
US4393883A (en) * 1980-11-03 1983-07-19 Medtronic, Inc. Single pass A-V lead
US4628944A (en) * 1982-02-08 1986-12-16 Cordis Corporation Cardiac pacing lead with biodegradable fixation structure
US4989617A (en) * 1989-07-14 1991-02-05 Case Western Reserve University Intramuscular electrode for neuromuscular stimulation system
US5071407A (en) * 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5224491A (en) * 1991-01-07 1993-07-06 Medtronic, Inc. Implantable electrode for location within a blood vessel
US5170802A (en) * 1991-01-07 1992-12-15 Medtronic, Inc. Implantable electrode for location within a blood vessel
US5246014A (en) * 1991-11-08 1993-09-21 Medtronic, Inc. Implantable lead system
US5231996A (en) * 1992-01-28 1993-08-03 Medtronic, Inc. Removable endocardial lead
DE69315704T3 (en) * 1992-10-01 2002-08-01 Cardiac Pacemakers Inc STENT-LIKE STRUCTURE FOR DEFLICTION ELECTRODES
US5755766A (en) * 1997-01-24 1998-05-26 Cardiac Pacemakers, Inc. Open-ended intravenous cardiac lead
US5954761A (en) * 1997-03-25 1999-09-21 Intermedics Inc. Implantable endocardial lead assembly having a stent
US5991668A (en) * 1997-09-25 1999-11-23 Medtronic, Inc. Medical electrical lead
US6070104A (en) * 1997-11-28 2000-05-30 Medtronic, Inc. Medical electrical right atrium and coronary sinus lead
US5908447A (en) * 1998-02-06 1999-06-01 Intermedics Inc. Breakaway structure for body implantable medical device
US5931864A (en) * 1998-02-20 1999-08-03 Cardiac Pacemakers, Inc. Coronary venous lead having fixation mechanism
US5925073A (en) * 1998-02-23 1999-07-20 Cardiac Pacemakers, Inc. Intravenous cardiac lead with wave shaped fixation segment
US5902331A (en) * 1998-03-10 1999-05-11 Medtronic, Inc. Arrangement for implanting an endocardial cardiac lead
US5964795A (en) * 1998-03-13 1999-10-12 Medtronic, Inc. Medical electrical lead
US6161047A (en) * 1998-04-30 2000-12-12 Medtronic Inc. Apparatus and method for expanding a stimulation lead body in situ
US6094596A (en) * 1998-06-19 2000-07-25 Angeron Corporation Transvenous defibrillation lead system for use in middle cardiac vein
US6321123B1 (en) * 1999-03-08 2001-11-20 Medtronic Inc. J-shaped coronary sinus lead
US6161029A (en) * 1999-03-08 2000-12-12 Medtronic, Inc. Apparatus and method for fixing electrodes in a blood vessel
DE19912635A1 (en) * 1999-03-20 2000-09-21 Biotronik Mess & Therapieg Dilatable cardiac electrode arrangement for implantation, particularly in the coronary sinus of the heart
US6136021A (en) * 1999-03-23 2000-10-24 Cardiac Pacemakers, Inc. Expandable electrode for coronary venous leads
US6445958B1 (en) * 1999-04-15 2002-09-03 Intermedics, Inc. Steerable coronary sinus defibrillation lead
US6632223B1 (en) * 2000-03-30 2003-10-14 The General Hospital Corporation Pulmonary vein ablation stent and method
US6289251B1 (en) * 1999-11-01 2001-09-11 Medtronic, Inc. High strength medical electrical lead
US6549812B1 (en) * 1999-11-29 2003-04-15 Medtronic, Inc. Medical electrical lead having bending stiffness which increase in the distal direction
DE19963602A1 (en) * 1999-12-23 2001-06-28 Biotronik Mess & Therapieg Two-chamber single-pass electrode arrangement
US6516230B2 (en) * 2000-04-26 2003-02-04 Medtronic, Inc. Medical electrical lead with fiber core
US6584362B1 (en) * 2000-08-30 2003-06-24 Cardiac Pacemakers, Inc. Leads for pacing and/or sensing the heart from within the coronary veins
US6697676B2 (en) * 2000-12-21 2004-02-24 Medtronic, Inc. Medical electrical lead having an expandable electrode assembly
US6934589B2 (en) * 2000-12-29 2005-08-23 Medtronic, Inc. System and method for placing endocardial leads
WO2002053225A2 (en) * 2000-12-29 2002-07-11 Medtronic, Inc. Electrode system for stimulating the left heart chamber
US6909920B2 (en) * 2001-04-27 2005-06-21 Medtronic, Inc. System and method for positioning an implantable medical device within a body
US6738674B2 (en) * 2001-07-25 2004-05-18 Oscor Inc. Implantable coronary sinus lead with mapping capabilities
US6711443B2 (en) * 2001-07-25 2004-03-23 Oscor Inc. Implantable coronary sinus lead and method of implant
US20030032936A1 (en) * 2001-08-10 2003-02-13 Lederman Robert J. Side-exit catheter and method for its use
US6936040B2 (en) * 2001-10-29 2005-08-30 Medtronic, Inc. Method and apparatus for endovenous pacing lead
US6745079B2 (en) * 2001-11-07 2004-06-01 Medtronic, Inc. Electrical tissue stimulation apparatus and method
KR100454143B1 (en) * 2001-11-19 2004-10-26 주식회사 하이닉스반도체 Flash memory device and method of erasing the same
US6961621B2 (en) * 2001-12-04 2005-11-01 Cardiac Pacemakers, Inc. Apparatus and method for stabilizing an implantable lead
DE10205721A1 (en) * 2002-02-12 2003-08-21 Biotronik Mess & Therapieg Guide wire and implantable lead
US6889091B2 (en) * 2002-03-06 2005-05-03 Medtronic, Inc. Method and apparatus for placing a coronary sinus/cardiac vein pacing lead using a multi-purpose side lumen
US20030199961A1 (en) * 2002-04-03 2003-10-23 Bjorklund Vicki L. Method and apparatus for fixating a pacing lead of an implantable medical device
US7386351B2 (en) * 2002-04-30 2008-06-10 Medtronic, Inc. Method and apparatus for placing a coronary sinus/cardiac vein pacing and defibriliation lead with adjustable electrode spacing
US7076309B2 (en) * 2002-04-30 2006-07-11 Medtronic, Inc. Apparatus and method for fixedly engaging an electrical lead
US20030203704A1 (en) * 2002-04-30 2003-10-30 Roger Dahl Apparatus and method for implanting an electrical lead
US7107105B2 (en) * 2002-09-24 2006-09-12 Medtronic, Inc. Deployable medical lead fixation system and method
US7313445B2 (en) * 2002-09-26 2007-12-25 Medtronic, Inc. Medical lead with flexible distal guidewire extension
US7031777B2 (en) * 2002-09-27 2006-04-18 Medtronic, Inc. Cardiac vein lead with flexible anode and method for forming same
US6871085B2 (en) * 2002-09-30 2005-03-22 Medtronic, Inc. Cardiac vein lead and guide catheter
US7103418B2 (en) * 2002-10-02 2006-09-05 Medtronic, Inc. Active fluid delivery catheter
US7195628B2 (en) * 2002-12-11 2007-03-27 St. Jude Medical, Atrial Fibrillation Division, Inc. Atrial fibrillation therapy with pulmonary vein support
US7187982B2 (en) * 2003-08-08 2007-03-06 Medtronic, Inc. Medical electrical lead anchoring
US7499759B2 (en) * 2003-10-24 2009-03-03 Cardiac Pacemakers, Inc. Distal or proximal fixation of over-the-tether myocardial leads

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP1722847A4 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729883B2 (en) 2002-09-24 2020-08-04 Medtronic, Inc. Lead delivery device and method
US9480839B2 (en) 2002-09-24 2016-11-01 Medtronic, Inc. Lead delivery device and method
US9636499B2 (en) 2002-09-24 2017-05-02 Medtronic, Inc. Lead delivery device and method
US9713709B2 (en) 2002-09-24 2017-07-25 Medtronic, Inc. Lead delivery device and method
US7865249B2 (en) 2006-09-22 2011-01-04 Cardiac Pacemakers, Inc. Means to securely fixate pacing leads and/or sensors in vessels
US8712553B2 (en) 2006-09-22 2014-04-29 Cardiac Pacemakers, Inc. Means to securely fixate pacing leads and/or sensors in vessels
WO2008095671A3 (en) * 2007-02-07 2009-02-26 Creganna Technologies Ltd Method of making cobalt-based alloy tubes having enhanced mechanical performance characteristics and a tube formed by the method
WO2008095671A2 (en) 2007-02-07 2008-08-14 Creganna Technologies Limited Method of making cobalt-based alloy tubes having enhanced mechanical performance characteristics and a tube formed by the method
WO2009042250A1 (en) 2007-09-26 2009-04-02 Cardiac Pacemakers, Inc. Left-ventricular lead fixation device in coronary veins
WO2009158444A1 (en) * 2008-06-27 2009-12-30 Medtronic, Inc. Lead delivery device and method
US9775990B2 (en) 2008-06-27 2017-10-03 Medtronic, Inc. Lead delivery device and method
US9849279B2 (en) 2008-06-27 2017-12-26 Medtronic, Inc. Lead delivery device and method
US9775989B2 (en) 2008-06-27 2017-10-03 Medtronic, Inc. Lead delivery device and method
US11931523B2 (en) 2008-06-27 2024-03-19 Medtronic, Inc. Lead delivery device and method

Also Published As

Publication number Publication date
US7797053B2 (en) 2010-09-14
WO2005053784A3 (en) 2006-10-19
US20060009830A1 (en) 2006-01-12
EP1722847A2 (en) 2006-11-22
US20050080472A1 (en) 2005-04-14
EP1722847A4 (en) 2008-05-14

Similar Documents

Publication Publication Date Title
US7797053B2 (en) Lead stabilization devices and methods
US7801627B2 (en) Cardiac lead having self-expanding fixation features
US6934589B2 (en) System and method for placing endocardial leads
US6697677B2 (en) System and method for placing a medical electrical lead
US7865249B2 (en) Means to securely fixate pacing leads and/or sensors in vessels
US7477946B2 (en) Fixation device for coronary venous lead
JP4620679B2 (en) Myocardial lead attachment system
JP4922942B2 (en) Filter sending system
EP3407964B1 (en) Compact implantable medical device and delivery device
US8019438B2 (en) Anchor for electrode delivery system
JP5327875B2 (en) Expandable member for intravenous lead fixation
JP2009504331A (en) Fixing and removing leads
US9108025B2 (en) Apparatus and method for anchoring an elongated object in body lumens
US20110015714A1 (en) Lead stabilization devices and methods
Kutarski et al. Breakage of extracted leads: another management option
US20090082838A1 (en) Left-ventricular lead fixation device in coronary veins

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 11139894

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2005139894

Country of ref document: US

Kind code of ref document: A

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2004794493

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004794493

Country of ref document: EP